CURRICULUM VITAE
NAME
Morris Mosseri,
ID: 6076975-9
Associate Professor in Medicine, Cardiology
(Tel-Aviv University)
FACULTY/DEPT
Tel-Aviv University, Sackler Medical School,
Cardiology
HOSPITAL/DEPT
Meir Medical Center, Cardiology
Tel: (972) 9-7472587
HOME ADDRESS
68 Hantke St, Jerusalem Israel 96629
Tel: (972) -2-6412094
DATE AND PLACE OF
BIRTH:
December 3, 1951, Egypt
DATE OF ARRIVAL IN
ISRAEL
April, 1957
ZAHAL (ISRAELI)
MILITARY SERVICE
May 1, 1977
(Enlisted
MARITAL STATUS
Married
NO. OF CHILDREN
3 children
A.
Education
PERIOD OF STUDY
April 30, 1982
Discharged)
1969-1975 Medical School of the Hebrew
University and Hadassah, Jerusalem, Israel. MD
degree.
Professional Licensure and Certifications:
1976 Board of Registration in Medicine, Israel
1976 ECFMG Certificate
1983 VQE Certificate
1987 Board Certificate in Cardiology (Israel)
1991 Board of Registration in Medicine, Boston
MA
2006 European Cardiologist Diploma
Name: Morris Mosseri
Title of Doctoral
Dissertation:
Name of
Supervisor
Degree: MD
CV: updated 1.4.2010
"Evaluation of the examinations performed with the
computerized echoencephalography in 2,000
patients".
Prof. Herishanu, Hadassah Medical Center
B. FURTHER
STUDIES
Period of Study
(dates)
1981-1984 Resident and senior resident, Internal
Medicine Department, Hadassah University
Hospital, Mt. Scopus, Jerusalem, Israel.
1984-1986 Fellow, Cardiology Department,
Hadassah University Hospital, Ein-Kerem
Jerusalem, Israel.
8/1988 Fellow in the 21st International Teaching
Seminar on Cardiovascular Epidemiology and
Prevention, The Netherlands (International Society
and Federation of Cardiology/ The World Health
Organization).
2
Name: Morris Mosseri
Degree: MD
C. ACADEMIC AND PROFESSIONAL EXPERIENCE
(FOR MDs – ACADEMIC EXPERIENCE; CLINICAL
CV: updated 1.4.2010
EXPERIENCE)
TEACHING ACADEMIC APPOINTMENTS:
3/82
3/86
2/90 - 6/92
2/92
3/99-5/2007
Instructor in Internal Medicine, Hadassah University
Medical School, Jerusalem, Israel
Lecturer in Internal Medicine, Hadassah University
Medical School, Jerusalem, Israel.
Assistant Professor in Medicine, Tufts University
Medical School, Boston, MA. U.S.A.
Senior Lecturer in Internal Medicine (Cardiology),
Hadassah Hebrew University Medical School,
Jerusalem, Israel.
Associate Professor in Medicine (Cardiology),
Hadassah University Medical School, Jerusalem,
Israel.
PROFESSIONAL APPOINTMENTS:
1987-2006
Staff Senior Cardiologist, Cardiology Department,
Hadassah University Hospital, Ein-Kerem, Jerusalem,
Israel.
1987-2000
Co-Director of Catheterization and Inpatient Cardiology
Units. Hadassah University Hospital, Ein-Kerem
Jerusalem, Israel.
8/1989-8/1991 Research Associate, Department of Medicine, Division
of Cardiology, St. Elizabeth's Hospital, Boston, MA.
1998
Research Associate, Cardiovascular Research
Foundation, Cardiology Department, Washington
Hospital Center, Washington DC., U.S.A.
2000-2003
Head of the Internal Medicine Section, Hebrew
University and Hadassah Medical School, Jerusalem,
Israel.
1/2000-11/2006 Director of Interventional Cardiology, Hadassah
Hebrew University Medical center, Jerusalem Israel.
Deputy Head of the Heart Institute, Hadassah Hebrew
University Medical center, Jerusalem Israel.
11/05-11/06
Director of the Excellence Center for Vascular
Diseases, Hadassah Hebrew University Medical
center, Jerusalem Israel.
Since 1.11.2006 Head of Cardiology Division,
Meir Medical Center, Kfar-Saba, Israel.
Performed over 12,000 diagnostic heart catheterizations and 5000
therapeutic heart catheterization. In addition, performed diagnostic
and therapeutic catheterizations in peripheral arteries including
subclavian, renal and lower limbs.
3
Name: Morris Mosseri
Degree: MD
CV: updated 1.4.2010
ADDITIONAL ACADEMIC AND PROFESSIONAL APPOINTMENTS
1987-1989,
and 1992-1995 Director of Cardiology Courses for 6th Year Medical
Students, Hadassah Hebrew University Medical School
1995
Member, Guidelines for Treatment of Post MI
Patients in the Community Committee
1997
Member, Steering Committee of the ICDC Cardiovascular Diseases, Ministry of Health, Israel
1992-2003
Member, Medical Students Admitting Committee,
Hebrew-University Hadassah Medical School
1995-1997
Deputy-Editor of Cardiology Update Journal.
1993-2000
Member, Graduating Examinations Committee,
Hebrew-University Hadassah Medical School
1997-2003
Editor, The Journal of Israel Heart Society
1999-2003
Chair, Radiation Committee, Interventional
Cardiology, The Israel Heart Society.
2001-2003
Chair, Committee for Technology advancement,
Hadassah Medical Center, Jerusalem
Since 2003
Member, The National Council for Diabetes Mellitus
2004-2006
Director of Phase II Cardiology Board Examinations
2005-2006
Member of the Committee for Academic Exchange
Programs, Hadassah Hebrew University Medical
Center
2005-2009
Chairman of the Israeli Working Group on
Interventional Cardiology, The Israeli Heart Society
4
Name: Morris Mosseri
Degree: MD
CV: updated 1.4.2010
D. ACTIVE PARTICIPATION IN SCIENTIFIC MEETINGS
17/5/1995
Co-director of an Israeli Meeting: The Diabetic Heart,
Jerusalem, Israel.
24-27/6/2002 Member of Organizing Committee and Chairperson of
a Session: Insights from basic science: What does the
future look like? The 3rd International Meeting on
Intensive Cardiac Care, Tel-Aviv, Israel.
3-4/4/2003
Director of post graduate courses: "Modern Trends un
Invasive Cardiology", Sofia and Plovdiv, Bulgaria
30/4-1/5 2003 Chairperson of a session: “Interventional Cardiology”.
The 50th Annual Meeting of the Israel Heart Society.
Tel-Aviv, Israel.
19-22/10/2003 Co-Chair of a plenary session: Drug-eluting stents and
brachytherapy, where do we stand? The 5th
International Congress on Coronary Artery disease From Prevention to Intervention. Florence, Italy.
7-9/12/2003
Co-Chair of a plenary session. The 5th International
Meeting on Interventional Cardiology: Frontiers in
Interventional Cardiology. Tel-Aviv, Israel.
7-9/12/2003
Moderator at a Plenary Session. Clinical management
beyond the cath lab. The 5th International Meeting on
Interventional Cardiology: Frontiers in Interventional
Cardiology. Tel- Aviv, Israel.
21/4/2004
Co-Chair of a session: Cardiovascular Medicine. The
2nd Israel Meeting on Geriatric Medicine. Tel-Aviv,
Israel.
28-29/4/2004 Co-Chair of a session: Myocardial Injury and Repair.
The 51st Annual Meeting of the Israel Heart Society.
Tel-Aviv, Israel.
6-7/12/2004
Member of the Program Committee and Local Advisory
Committee, and Chair of sessions: I.Percutaneous
Valvular Interventions. II. Case transmissions
(Columbia Medical Center NY). The 6th International
Meeting on Interventional Cardiology. Tel-Aviv, Israel.
29/10-1/11/2005 Co-Chair of a session: Acute Coronary Syndromes,
Acute Myocardial Infarction. 6th International
Congress on Coronary Artery Disease: From
Prevention to Intervention. Istanbul, Turkey.
12-14/1/2006
3/3/2006
Co-chair of the Annual Meeting of the Working Group
on Interventional Cardiology. Haifa, Israel.
Co-chair of a Meeting of the Israeli Working Groups on
Interventional Cardiology and Intensive Cardiac Care
Unit. PCI in acute MI. Tel-Aviv, Israel.
5
Name: Morris Mosseri
23/3/2006
Degree: MD
CV: updated 1.4.2010
Co-Chair of a session: Cardiovascular Interventions.
The 1st Israeli Workshop on Transradial Coronary
Intervention. Jerusalem, Israel.
26-27/4/2006 Co-Chair of a session: Interventional Cardiology –
Primary PCI in Acute MI. The 53rd Annual Meeting of
the Israel Heart Society. Tel-Aviv, Israel.
14-18/5/2006 Member of Local Organizing Committee. The 19th
International Congress on Thrombosis. Tel-Aviv,
Israel.
16-19/5/2006 Chairperson of Case Review session: Urgent Valvular
Interventions. The EuroPCR meeting. Paris, France.
26-29/10/2006 Member of the International Scientific Committee. The
1st World Congress on Controversies in Obesity,
Diabetes and Hypertension (CODHy). Berlin,
Germany.
3-5/12/2006
Member of the Program Committee and Local Advisory
Committee. Innovations in Cardiovascular
Interventions (ICI) Meeting. Tel-Aviv, Israel.
5/12/2006
Co-Chair of a session: Endovascular and Carotid
Innovations. Innovations in Cardiovascular
Interventions (ICI) Meeting. Tel-Aviv, Israel.
18-19/4/2007 Co-Chair of a session: Interventional Cardiology. The
54th Annual Meeting of the Israel Heart Society. TelAviv, Israel.
22-25/5/2007 Chairperson of Case Review session: PCI dilemmas
and controversies in STEMI. The EuroPCR meeting.
Barcelona, Spain.
5-7/7/2007
Co-chair of a Meeting of the Working Group on
Interventional Cardiology. Interventional Cardiology in
Diabetic Patients. Eilat, Israel.
5-7/7/2007
Co-chair of the Annual Meeting of the Working Group
on Interventional Cardiology: Interventional Cardiology
in DM patients. Eilat, Israel.
7-10/10/2007 Co-chair of a session: New Frontiers in Interventional
and Surgical Revascularization. 7th International
Congress on Coronary Artery Disease; From
Prevention to Intervention. Venice, Italy.
14-16/10/2007 Member of the Local Faculty and Organizing Committee of
the 5th International Meeting on Intensive Cardiac Care.
Tel Aviv, Israel.
14-16/10/2007 Co Chair of session: PCI and beyond for acute MI. 5th
International Meeting on Intensive Cardiac Care. Tel Aviv,
Israel.
20-25/10/2007 Discussant. Session III: The Elderly Patient.
Roundtable Discussion: New Choices for Old Patients?
TCT 2007. Washington DC, U.S.A..
20-25/10/2007 Discussant. Interventional Strategies and Adjunct
Pharmacology in ACS and AMI STEMI. Session VII: The
Open Artery Hypothesis and Other Controversies.
Moderated Discussion and Audience Q & A. TCT 2007.
Washington DC, U.S.A.
20-25/10/2007 Live Case Discussant. Structural Heart Disease Theater.
6
Name: Morris Mosseri
2-4/12/2007
21/2/2008
9-10/4/2008
24/5/2008
17/6/2008
11/7/2008
19/12/2008
20/3/2009
22-23/4/2009
22-23/4/2009
25-27/10/2009
25-27/10/2009
25-27/10/2009
6-8/12/2009
6-8/12/2009
8-10/2/2010
14-15/4/2010
Degree: MD
CV: updated 1.4.2010
Case Session VI. Live and Taped. TCT 2007.
Washington DC, U.S.A.
Member of the Program Committee and Moderator of
live case transmission in: Innovation in Cardiovascular
Interventions Meeting. Tel-Aviv, Israel.
Co-chair of the 1st Interdisciplinary Israeli Conference
on Cardiovascular CT Angiography. Tel-Aviv, Israel.
Co-Chair of a session: Basic Science and
Interventions. The 55th Annual Meeting of the Israel
Heart Society. Tel-Aviv, Israel.
Chairperson of Case Review session: PCI in the
Elderly. The EuroPCR meeting. Barcelona, Spain.
Co-chair of live case session in: Horizons in
Interventional Cardiology. Rambam Medical Center,
Haifa, Israel.
Co-chair of the Meeting of the Israeli Working Group on
Interventional Cardiology. Thrombosis and Bleeding
Complications in ACS and following PCI. Tel-Aviv,
Israel.
Co-chair of the Meeting of the Israeli Working Groups
on Interventional Cardiology and Intensive Cardiac
Care Unit. ACSIS 2008. Tel-Aviv, Israel.
Co-chair of the Meeting of the Israeli Working Group on
Interventional Cardiology. Evidence Based Medicine to
optimize DES utilization. Tel-Aviv, Israel.
Co-Chair of a session: Anti-thrombotic therapy post
ACS – How long? For whom? The 56th Annual
Meeting of the Israel Heart Society. Tel-Aviv, Israel.
Co-Chair of a session: Complications and outcome
following contemporary PCI. The 56th Annual Meeting
of the Israel Heart Society. Tel-Aviv, Israel.
Member of the Local Faculty and Organizing Committee of
the 6th International Meeting on Intensive Cardiac Care.
Tel Aviv, Israel.
Co-Chair of session: Primary PCI for STEMI – dilemmas
and controversies. 6th International Meeting on Intensive
Cardiac Care. Tel Aviv, Israel.
Co-Chair of session: Ethical issues in interventional
cardiology. 6th International Meeting on Intensive Cardiac
Care. Tel Aviv, Israel.
Co-Director and Organizing Committee: Innovation in
Cardiovascular Interventions Meeting. Tel-Aviv, Israel.
Co-Chair of session: Cardiovascular Interventions – A
Case Study Session. Innovation in Cardiovascular
Interventions Meeting. Tel-Aviv, Israel.
Co-Chair of session: Implantable Devices for
Management of Arrhythmias and HF. The 10th
International Dead Sea Symposium (IDSS) on Cardiac
Arrhythmias and Device Therapy. Tel-Aviv, Israel.
Co-Chair of a session: Interventional Cardiology –
PCI2. The 57th Annual Congress of the Israel Heart
Society. Tel-Aviv, Israel.
7
Name: Morris Mosseri
E.
Degree: MD
CV: updated 1.4.2010
MEMBERSHIP IN PROFESSIONAL SOCIETIES
Since 1977
Since 1987
Since 1994
Since 2006
Since 2006
Since 2006
Member of the Israel Medical Association
Member of the Israel Heart Society
Member of the International Society & Federation of
Cardiology, Council on Epidemiology and Prevention
Senior Faculty Member of the Peace Through Health
Institution, USA
Fellow of the European Society of Cardiology
Fellow of the European Association of Percutaneous
Cardiovascular Interventions
G. DOCTORAL STUDENTS SUPERVISED BY CANDIDATE IN THEIR THESIS
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
1994. Menachem Nahir. Diameter of coronaries in patients
with diabetes mellitus: The earliest phase of coronary artery
disease. Hadassah-Hebrew University Medical Center.
1995. Tami Izak. Coronary angiographic characteristics of
patients with permanent artificial pacemakers. HadassahHebrew University Medical Center.
1995. Einat Zolti-Popovtzer. The diameter of epicardial
coronaries arteries in patients with dilated cardiomyopathy.
Hadassah-Hebrew University Medical Center.
1997. Alex Briskin. Pulmonary hypertension in patients
candidate to lung transplantation; Influential factors and
prognostic significance.
1997. Alon Nechmead. Estrogen induces nitric oxidemediated vasodilation of human mammary arteries in-vitro.
Hadassah-Hebrew University Medical Center.
1998. Barak Haviv. The effect of external ionizing radiation
on the vasoreactivity of the rat aorta in-vitro.
2003. Reut Harel. Missed diagnosis of acute coronary
syndrome in patients presenting to the emergency room with
chest pain. Hadassah-Hebrew University Medical Center.
2004. Meir Angie. Is there an association between coronary
heart disease and oral bacteria and infectious diseases?
Hadassah-Hebrew University Medical Center.
2004. Nir Hadari. Preventing recurrence of in-stent
restenosis using gamma brachytherapy. Hadassah-Hebrew
University Medical Center.
2005. Renana Retig-Tauber. Can we improve the cardiac
patient's partnership in his / her recovery? Hadassah-Hebrew
University Medical Center.
2006. Gassan Muadi. Effect of repeated angiographies on
contrast nephropathy. Hadassah-Hebrew University Medical
Center.
2007. Sued Forat. The effect of delayed type
hypersensitivity to metals on the proportion of in-stent
8
Name: Morris Mosseri
Degree: MD
CV: updated 1.4.2010
restenosis after coronary stent implantation. HadassahHebrew University Medical Center.
H. PHYSICIANS SUPERVISED BY CANDIDATE IN THEIR BASIC SCIENCE PROJECT
1.
2.
3.
4.
5.
6.
1999. Dr. Menachem Nahir. The effect of hyperglycemia on
vasoreactivity in a diabetic mouse model. Hadassah-Hebrew
University Medical Center.
2002. Dr. Vadim Shatz. Correlation between cardiac
troponin, CPK-MB and post-operative cardiac ischemia, and
long term survival after major vascular surgery. HadassahHebrew University Medical Center.
2003. Dr. Tatiana Rozental-Ganon. Does pre-operative 12
lead ECG monitoring predict long term prognosis after
vascular surgery? Hadassah-Hebrew University Medical
Center.
2004. Dr. Helena Veselov. Pathophysiology and early
detection of myocardial infarction and mortality in critical
patients at the intensive care unit. Hadassah-Hebrew
University Medical Center.
2005. Dr. Hashem Ruchi. Pathophysiology of myocardial
damage in septic patients in the intensive care unit:
Inflammation, hyper-coagulability, myocardial stress or
prolonged ischemia? Hadassah-Hebrew University Medical
Center.
2006. Dr. Alexei Paker. Comparison of Pryor's clinical
parameters to radionuclide stress test for predicting coronary
artery disease. Hadassah-Hebrew University Medical Center.
9
Name: Morris Mosseri
Degree: MD
CV: updated 1.4.2010
Morris Mosseri, MD
April 2010
List of Publications
Original Articles in Peer Reviewed Journals
1.
Mosseri M, Shalev O, Menczel Y.
Paget Disease - diagnostic and radiological aspects.
Harefuah 103(9): 208-211, 1982.
2.
Mosseri M, Stalnikowicz R.
Diarrhea after abdominal surgery.
Harefuah 102(11): 498-499, 1982.
3.
Mosseri M, Shalev O, Menczel Y.
Paget Disease - diagnostic and radiological aspects.
Harefuah 103(9): 208-211, 1982.
4.
Shalev O, Mosseri M, Ariel I, Stalnikowicz R.
Methyl-dopa induced hemolytic anemia and chronic active hepatitis.
Arch Int Med 143: 592-593, 1983. (8/105, IF 8.01)
5.
Wolf E, Mosseri M, Beilin B, Vilozni D.
Body ventilation in chronic respiratory failure due to neuromuscular
disorders.
Harefuah 106(3): 120-122, 1984.
6.
Koren G, Weiss AT, Hasin Y, Applebaum D, Welber S, Lotan C,
Mosseri M, Sapoznikov D, Luria H, Gotsman MS.
Prevention of myocardial damage by very early treatment with
intravenous streptokinase.
N Engl J Med 313: 1384-1389, 1985. (1/105, IF 11.63)
7.
Hasin Y, Mosseri M, Kriwiski M, Koren G, Lotan C, Rozenman Y,
Gotsman MS.
Percutaneous transluminal coronary angioplasty in Hadassah EinKerem, current experience.
Harefuah 60(5): 223- 226, 1985.
8.
Lotan C, Welber S, Weiss AT, Sapoznikov D, Mosseri M, Rosenheck
S, Applebaum D, Fine DG, Koren G, Hasin Y, Gotsman MS.
Importance of early administration of intravenous streptokinase in
patients with acute myocardial infarction.
Harefuah 10: 277-280, 1986.
9.
Milgalter E, Mosseri M, Uretzki G, Applebaum A, Borman J.
Emergency CABG for acute myocardial ischemia following failed
PTCA.
Isr J Med Sci 22: 783-786, 1986. (IF 0.54)
10
Name: Morris Mosseri
Degree: MD
CV: updated 1.4.2010
10.
Mosseri M, Yarom R, Gotsman MS, Hasin Y.
Histological evidence for small coronary artery disease in patients with
angina pectoris and patent large coronary arteries.
Circulation 74: 964-972, 1986. (1/72, IF 11.63)
11.
Koren G, Luria H Weiss AT, Kriwiski M, Mosseri M, Lotan C,
Applebaum D, Hasin Y, Gotsman MS.
A high risk syndrome following early treatment of acute myocardial
infarction with intravenous streptokinase.
Arch Int Med 146: 237-240, 1987. (8/105, IF 8.01)
12.
Weiss AT, Fine DG, Applebaum, Welber S, Sapoznikov D, Lotan C,
Mosseri M, Hasin Y, Gotsman MS.
Prehospital coronary thrombolysis - a new strategy in acute myocardial
infarction.
Chest 92(1): 124-128, 1987. (3/33, IF 4.00)
13.
Mosseri M, Oppenheim D, Kahn K, Raz E.
Diarrhea and bone marrow depression induced by nomifenzine
maleate.
Isr J Med Sci 23: 906, 1987. (IF 0.54)
14.
Fine DG, Vinker S, Weiss AT, Welber S, Sapoznikov D, Lotan C,
Mosseri M, Rosenheck S, Hasin Y, Gotsman MS.
Influence of vessel involvement and early streptokinase therapy on
regional and global left ventricular function in acute myocardial
infarction.
Herz 12(6): 398-404, 1987. (53/72, IF 0.95)
15.
Sapoznikov D, Welber S, Lotan C, Mosseri M, Shimoni Y, Gotsman
MS.
Quantitation of variations in regional left ventricular function in
isolated disease of the left anterior descending coronary artery.
Cardiology 74: 444-456, 1987. (26/72, IF 2.09)
16.
Kriwiski M, Ackerman Z, Mosseri M, Gotsman MS, Hasin Y.
Right ventricular infarction: unusual electrocardiographic and
electrophysiological manifestations.
Clin Cardiol 10: 57-61, 1987. (47/72, IF 1.10)
17.
Mosseri M, Gotsman MS, Hasin Y.
Endomyocardial biopsy.
Harefuah 114: 445-447, 1988.
18.
Lotan C, Gurewitz J, Mosseri M, Weiss AT, Sapoznikov D, Hasin Y,
Gotsman MS.
Change in ventricular function and coronary stenosis after successful
streptokinase treatment in acute myocardial infarction.
Cardiology 75: 419-430, 1988. (26/72, IF 1.10)
11
Name: Morris Mosseri
Degree: MD
CV: updated 1.4.2010
19.
Sapoznikov D, Nizan M, Mosseri M, Mahler Y, Gotsman MS.
Assessment of left ventricular volumes using densitometry of x-ray
films.
IEEE Engineering in Medicine and Biology 10: 437-438, 1988. (9/18,
IF 1.23)
20.
Gurewitz J, Mosseri M, Lotan C, Sapoznikov D, Gotsman MS. Long
term angiographic follow up after patients treated with intravenous
streptokinase in acute myocardial infarction.
Harefuah 116(1): 6-11, 1989.
21.
Mosseri M, Admon D, Yarom R, Rosenheck S, Gotsman MS. Follow
up of heart transplant patients.
Harefuah 116(1): 17-21, 1989.
22.
Porath A, Mosseri M, Harman I, Ovsyshcher I, Keynan A.
Dead sea water poisoning.
Annals of Emergency Medicine 18: 187- 189, 1989. (2/11, IF 2.78)
23.
Grisaru D, Rachmilewitz EA, Mosseri M, Gotsman MS, Lafair JS,
Okon E, Goldfarb A, Hasin Y.
Cardiopulmonary assessment in beta-thalassemia major.
Chest 98(5): 1138-1142, 1990. (3/33, IF 4.00)
24.
Yarom R, Admon D, Ron N, Mosseri M, Sapoznikov D, Gotsman MS.
Capillary and myofiber ultrastructure in endomyocardial biopsies from
cyclosporin treated heart transplant patients.
J Heart Transplant 9: 187-196, 1990. (16/72, IF 2.99)
25.
Mosseri M, Admon D, Hasin Y, Kriwitzki M, Rosenheck S, Gotsman
MS.
Percutaneous angioplasty of totally occluded vein bypass grafts.
Angiology 41(1): 44-52, 1990. (IF 0.94)
26.
Mosseri M, Porath A, Ovsyshcher I, Stone D.
Electrocardiographic manifestations of combined hypercalcemia and
hypermagnesemia caused by near drowning in the dead sea. J
Electrocardiol 23: 235-241, 1990. (58/72, IF 0.85)
27.
Isner JM, Mosseri M.
Right ventricular myocardial infarction: clinical aspects.
Coronary Artery Disease 1: 287-297, 1990. (31/51, IF 1.52)
28.
Mosseri M, Meir G, Lotan C, Hasin Y, Applebaum A, Rosenheck S,
Shimon D, Gotsman MS.
Coronary pathology predicts conduction disturbances after coronary
artery bypass grafting.
Annals Thorac Surg 51: 248-252, 1991. (24/72, IF 2.22)
12
Name: Morris Mosseri
Degree: MD
CV: updated 1.4.2010
29.
Mosseri M, Schaper J, Admon D, Hasin Y, Gotsman MS, Sapoznikov
D, Pickering JG, Yarom R.
Coronary capillaries in patients with congestive cardiomyopathy or
angina pectoris with patent main coronary arteries; Ultrastructural
morphometry of endomyocardial biopsy samples.
Circulation 84: 203-210, 1991. (1/72, IF 11.63)
30.
Gotsman MS, Rosenheck S, Nassar H, Welber S, Sapoznikov D,
Mosseri M, Weiss AT, Lotan C, Rozenman Y.
Angiographic findings in the coronary arteries after thrombolysis in
acute myocardial infarction.
Am J Cardiol 70: 715-723, 1992. (15/72, IF 3.05)
31.
Gal D, Chokshi SK, Mosseri M, Clarke RH, Isner JM.
Percutaneous delivery of low level laser energy reverses histamineinduced spasm in atherosclerotic Yucatan microswine.
Circulation 85: 756-768, 1992. (1/72, IF 11.63)
32.
Isner JM, Pickering JG, Mosseri M.
Laser-induced dissections: Pathogenesis and implications for therapy.
J Am Coll Cardiol (JACC) 19: 1619-1621, 1992. (3/72, IF 9.20)
33.
Mosseri M, Isner JM, Lotan C, Rozenman Y, Gotsman MS. Advances
in percutaneous coronary revascularization.
Harefuah 124: 765-770, 1993. (Hebrew)
34.
Rozenman Y, Lotan C, Gilon D, Mosseri M, Sapoznikov D, Welber S,
Gotsman MS.
Arterial remodeling after percutaneous transluminal balloon
angioplasty.
Adv Exp Med Biol 346: 277-82, 1993. (64/72, IF 0.63)
35.
Mosseri M, Pickering JG, Chokshi SK, Gal D, Isner JM.
Excimer laser-induced vasoreactivity.
Eur Heart J 14: 1394-403, 1993. (4/72, IF 7.34)
36.
Mosseri M, Gotsman MS, Isner JM.
Laser-tissue interactions: Vascular reactivity.
Isr J Med Sci 29: 812-816, 1993. (IF 0.54)
37.
Landesberg G, Luria MH, Cotev S, Eidelman LA, Anner H, Mosseri M,
Schechter D, Assaf J, Erel J, Berlatzky Y.
Importance of long-duration postoperative ST-segment depression in
cardiac morbidity after vascular surgery.
Lancet 341: 715-719, 1993. (2/105, IF 23.40)
38.
Mosseri M, Barlett-Pandite AN, Wenc Karen, Isner JM, Weinstein R.
Inhibition of endothelium-dependent vasorelaxation by sickle
erythrocytes.
Am Heart J 126:338- 346, 1993. (12/72, IF 3.55)
13
Name: Morris Mosseri
Degree: MD
CV: updated 1.4.2010
39.
Mosseri M, Varticovski L, Fingert H, Chokshi SK, Isner JM.
In-vitro evidence that myocardial ischemia resulting from 5Fluorouracil is due to protein kinase C-mediated vasoconstriction of
vascular smooth muscle.
Cancer Research 53, 3028- 3033, 1993. (11/123, IF 7.61)
40.
Rozenman Y, Gotsman MS, Weiss AT, Lotan C, Mosseri M,
Sapoznikov D, Welber S, Nassar H, Hasin Y, Gilon D.
Very early thrombolysis in acute myocardial infarction - a light at the
end of the tunnel.
Isr J Med Sci 30: 99-107, 1994. (IF 0.54)
41.
Mosseri M, Rozenman Y, Lotan Y, Gotsman MS.
Clinical considerations in percutaneous transluminal coronary
angioplasty.
Harefuah 127: 393-396, 1994.(Hebrew)
42.
Rozenman Y, Mosseri M, Lotan C, Gotsman MS.
The vascular stent in percutaneous transluminal coronary angioplasty.
Harefuah, 126: 693-696; 1994. (Hebrew)
43.
Rozenman Y, Gilon D, Welber S, Sapoznikov D, Wexler D, Lotan C,
Mosseri M, Weiss AT, Hasin Y, Gotsman MS.
Total coronary artery occlusion late after successful coronary
angioplasty of moderately severe lesions: Incidence and clinical
manifestations.
Cardiology 85: 222-228; 1994. (26/72, IF 2.09)
44.
Berlatzky Y, Landesberg G, Anner H, Luria MH, Eidelman LA,
Mosseri M.
Prolonged postoperative myocardial ischemia and infarction in
vascular surgery performed under regional anesthesia.
Eur J Vasc Surg 8: 413-418; 1994. (28/129, IF 2.02)
45.
Lotan C, Mosseri M, Rozenman Y, Hasin Y, Gotsman MS. Combined
mechanical and thrombolytic treatment for totally occluded bypass
grafts.
Br Heart J 74: 455-459, 1995. (8/72, IF 3.78)
46.
Rozenman Y, Lotan C, Mosseri M, Gotsman MS.
Relation of thrombotic occlusion of coronary stents to the indication
for stenting, stent size, and anticoagulation.
Am J Cardiol 75: 84-85; 1995. (15/72, IF 3.05)
47.
Rozenman Y, Gilon D, Zelinger J, Lotan C, Mosseri M, Geist M,
Weiss AT, Hasin Y, Gotsman MS.
One-stage coronary angiography and angioplasty.
Am J Cardiol 75: 30-33; 1995. (15/72, IF 3.05)
14
Name: Morris Mosseri
Degree: MD
CV: updated 1.4.2010
48.
Rozenman Y, Rosenheck H, Nassar H, Welber S, Sapoznikov D, Lotan
C, Mosseri M, Weiss AT, Gotsman MS.
Acute myocardial infarction - the angiographic picture: new insights
into the pathogenesis of myocardial infarction.
Int J Cardiol 49: 11s-16s; 1995. (32/72, IF 1.76)
49.
Rozenman Y, Gotsman MS, Weiss AT, Lotan C, Mosseri M,
Sapoznikov D, Welber S, Hasin Y, Gilon D.
Early intravenous thrombolysis in acute myocardial infarction: the
Jerusalem Experience.
Int J Cardiol 49: 21s-28s; 1995. (32/72, IF 1.76)
50.
Avital S, Waksman R, Rozenman Y, Mosseri M, Lotan C, Hasin Y,
Gotsman MS.
Percutaneous angioplasty of saphenous vein grafts and coronary
arteries after aorto-coronary artery bypass surgery.
Harefuah 129: 96-99; 1995 (Hebrew).
51.
Lotan C, Hasin Y, Mosseri M, Rozenman Y, Gotsman Y. Transradial
approach for coronary angiography and angioplasty - experience with
the first 100 patients.
Am J Cardiol 76: 164-167; 1995. (15/72, IF 3.05)
52.
Lotan C, Jonas M, Rozenman Y, Mosseri M, Benhorin J, Rudnik L,
Hasin Y, Gotsman MS.
Comparison of early invasive and conservative treatments in patients
with anterior wall non-Q-wave acute myocardial infarction.
Am J Cardiol 76: 330-336; 1995. (15/72, IF 3.05)
53.
Rozenman Y, Gilon D, Welber S, Sapoznikov D, Lotan C, Mosseri M,
Weiss AT, Hasin Y, Gotsman MS.
Influence of coronary angioplasty on the progression of coronary
atherosclerosis.
Am J Cardiol 76: 1126-1130, 1995. (15/72, IF 3.05)
54.
Rozenman Y, Gilon D, Zelinger J, Sapoznikov D, Lotan C, Mosseri M,
Weiss AT, Hasin Y, Gotsman MS.
Age and gender related differences in success, major and minor
complication rates and the duration of hospitalization after
percutaneous transluminal coronary angioplasty.
Cardiology 87(5): 396-401, 1996. (26/72, IF 2.09)
55.
Lichtenstein DA, Klapholtz L, Vardy DA, Leichter I, Mosseri M,
Klaus SN, Gilead LT.
Chronic radiodermatitis following cardiac catheterization.
Arch Dermatology 132: 663-7, 1996. (2/33, IF 3.43)
56.
Rozenman Y, Gilon D, Zelinger J, Sapoznikov D, Lotan C, Mosseri M,
Weiss AT, Hasin Y, Gotsman MS.
Importance of delaying balloon angioplasty in patients with unstable
angina pectoris.
Clin Cardiol 19: 111-114, 1996. (47/72, IF 1.10)
15
Name: Morris Mosseri
Degree: MD
CV: updated 1.4.2010
57.
Medallion B, Merin G, Elami A, Milgalter E, Rudis E, Dviri E, Aner
C, Wolf Y, Eidelman L, Mosseri M, Schechter D, Berlatzki Y.
The therapeutic approach to patients with combined coronary and
carotid disease.
Harefuah 131: 79-82, 1996. (Hebrew)
58.
Rozenman Y, Lotan C, Mosseri M, Hasin Y, Gotsman MS. Improved
outcome of coronary stenting by utilizing a modified treatment
protocol.
Isr J Med Sci 32: 722-25, 1996. (IF 0.54)
59.
Rozenman Y, Lotan C, Mosseri M, Nassar H, Hasin Y,
Gotsman MS. Experience with the AVE Microstent in native coronary
arteries.
Am J Cardiol 78: 685-7, 1996. (15/72, IF 3.05)
60.
Gotsman MS, Mosseri M, Rozenman Y, Admon D, Lotan C,
Nassar H.
Atherosclerosis studies by intracoronary ultrasound.
Adv Exp Med Biol, 430: 197-212, 1997. (64/72, IF 0.63)
61.
Rozenman Y, Lotan C, Mosseri M, Nassar H, Hasin Y,
Gotsman MS.
Recent experience with percutaneous recanalization of “protected” left
main new angioplasty devices.
J Invasive Cardiol 9: 475-478, 1997. (IF 0.25)
62.
Landesberg G, Einav S, Christopherson R, Beattie C, Berlatzky Y,
Rosenfeld B, Eidelman LA, Norris E, Anner H, Mosseri M, Cotev S,
Luria MH.
Perioperative ischemia and cardiac complications in major vascular
surgery: Importance of the preoperative 12-lead ECG.
J Vascular Surg 26: 570-8, 1997. (13/137, IF 3.31)
63.
Gotsman MS, Rozenman Y, Admon D, Mosseri M, Lotan C, Zahger
D, Weiss AT.
Changing paradigms in thrombolysis in acute myocardial infarction.
Int J Cardiol 59: 227-242, 1997. (32/72, IF 1.76)
64.
Lotan C, Hasin Y, Salmoirago E, Rozenman Y, Mosseri M, Admon D,
Nassar H, Gotsman MS.
The radial artery: An applicable approach to complex coronary
angioplasty.
J Invasive Cardiol 9: 518-522, 1997. (IF 0.25)
65.
Gotsman MS, Weiss AT, Rozenman Y, Lotan C, Mosseri M.
Prehospital thrombolysis in acute myocardial infarction salvages
myocardium.
J Invasive Cardiol 10: 315-325, 1997. (IF 0.25)
16
Name: Morris Mosseri
Degree: MD
CV: updated 1.4.2010
66.
Rozenman Y, Gilon D, Sapoznikov D, Lotan C, Mosseri M, Hasin Y,
Gotsman MS.
Angiographic deterioration of target coronary artery narrowing as a
result of percutaneous balloon angioplasty.
Am Heart J 133 (5): 575-579, 1997. (12/72, IF 3.55)
67.
Mosseri M, Zolti E, Rozenman Y, Lotan C, Ershov t, Izak T, Admon
D, Gotsman MS.
The diameter of epicardial coronaries arteries in patients with dilated
cardiomyopathy
Int J Cardiol 62: 133-141, 1997. (32/72, IF 1.76)
68.
Rozenman Y, Mereuta A, Mosseri M, Lotan C, Nassar H, Hasin Y,
Gotsman MS.
Initial experience with long coronary stents - the changing practice of
coronary angioplasty.
Am Heart J 134: 355-361, 1997. (12/72, IF 3.55)
69.
Rozenman Y, Sapoznikov D, Mosseri M, Gilon D, Lotan C, Nassar C,
Weiss AT, Hasin Y, Gotsman MS.
Long term angiographic follow-up of coronary balloon angioplasty in
patients with diabetes mellitus: a clue to the explanation of the results
of the BARI study.
J Am Coll Cardiol (JACC) 30; 1420-5, 1997. (3/72, IF 9.20)
70.
Mosseri M, Izak T, Rosenheck S, Lotan C, Rozenman Y, Zolti E,
Admon D, Gotsman MS.
Coronary angiographic characteristics of patients with permanent
artificial pacemakers.
Circulation 96: 809-815, 1997. (1/72, IF 11.63)
71.
Mosseri M, Nahir M, Rozenman Y, Lotan C, Admon D, Raz I,
Gotsman MS.
Diffuse narrowing of coronary arteries in diabetic patients: The
earliest phase of coronary artery disease.
Cardiology 89: 103-110, 1998. (26/72, IF 2.09)
72.
Mosseri M, Rozenman Y, Mereuta A, Hasin Y, Lotan C,
Gotsman MS. Gap index - a new indicator for stent covering area.
J Cath Cardiovasc Diag 44: 188-192, 1998. (36/72, IF 1.60)
73.
Rozenman Y, Yershov T, Mosseri M, Gotsman MS.
Quantitative videodensitometric technique for verification of optimal
coronary stent implantation.
Int J Med Inform 51: 51-57, 1998. (7/18, IF 1.37)
74.
Landesberg G, Wolf Y, Schechter D, Mosseri M, Weissman C, Anner
H, Chisin R, Luria MH, Kovalski N, Bocher M, Erel J, Berlatzky Y.
Preoperative thallium scanning, selective coronary revascularization,
and long-term survival after carotid endarterectomy.
Stroke 29: 2541-8, 1998. (IF 5.85)
17
Name: Morris Mosseri
Degree: MD
CV: updated 1.4.2010
75.
Nechmad A, Merin G, Schwalb H, Shimon DV, Borman JB, Milgalter
E, Gotsman MS, Mosseri M.
Estrogen induces nitric oxide-mediated vasodilation of human
mammary arteries in-vitro.
Nitric Oxide Biol Chem 2(6): 460-6, 1998. (87/153, IF 2.16)
76.
Mosseri M, Gotsman MS, Mendelson S, Weshler Z.
Ionizing irradiation for the prevention of coronary and peripheral
restenosis.
Harefuah 136(6): 463-469, 1999.
77.
Mosseri M, Schwalb H, Weshler Z.
Prevention of restenosis by external beam ionizing radiation.
J Intervent Cardiol 12(4): 283-290, 1999. (IF 0.33)
78.
Gare M, Haviv Y, Ben-Yehuda A, Rubinger D, Fuchs S, BdolahAbram T, Gat O, Popovitzer MM, Gotsman MS, Mosseri M.
The renal effect of low-dose dopamine in high-risk patients undergoing
coronary angiography.
J Am Coll Cardiol (JACC) 34: 1682-8, 1999. (3/72, IF 9.20)
79.
Rozenman Y, Mereuta A, Schechter D, Mosseri M, Lotan C, Nassar H,
Weiss AT, Hasin Y, Chisin R, Gotsman MS.
Long term outcome of patients with very long stents for treatment of
diffuse coronary disease.
Am Heart J 138:441-5, 1999. (12/72, IF 3.55)
80.
Mosseri M, Beyar R, Guetta V, Meerkin D, Miller H.
Radiation Brachytherapy for the Prevention of Restenosis - a statement
of the Israel Invasive Cardiology Working Group, The Israel Heart
Society.
Harefuah 140: 361-4, 2001.
81.
Wolf YG, Landesberg G, Mosseri M, Schechter D, Anner H, Weisman
C, Berlatzky.
Preoperative dipyridamole-thallium scanning, selective coronary
revascularization and long-term survival in patients with critical lower
limb ischemia.
J Cardiovasc Surg 42: 89-95, 2001. (60/72, 0.82)
82.
Landesberg G, Mosseri M, Zahger D, Wolf Y, Perouansky M, Anner
H, Drenger B, Hasin Y, Berlatzky Y, Weissman C.
Myocardial infarction following vascular surgery: The role of
prolonged, stress-induced, ST-depression-type ischemia.
J Am Coll Cardiol (JACC) 37(7): 1839-45, 2001. (3/72, IF 9.20)
83.
Mosseri M , Haviv B, Weshler Z, Schwalb H. The Effect of Ionizing
Irradiation on Vasomotor Reactivity in the Rat Thoracic Aorta in-vitro.
Cardiovascular Revasc Medicine 2(3): 151-156, 2001 (The journal is
included in the Index Medicus. IF is not yet available).
18
Name: Morris Mosseri
Degree: MD
CV: updated 1.4.2010
84.
Landesberg G, Mosseri M, Wolf Y, Vesselov Y, Weissman C.
Perioperative myocardial ischemia and infarction identification by
continuous 12-lead electrocardiogram with online ST-segment
monitoring.
Anesthesiology 96:264 –70, 2002. (2/22, IF 4.00)
85.
Landesberg G, Mosseri M, Wolf YG, Bocher M, Basevitch A, Rudis E,
Izhar U, Anner H, Weissman C, Berlatzky Y.
Preoperative thallium scanning, selective coronary revascularization
and long-term survival following major vascular surgery.
Circulation 108: 177-183, 2003. (1/72, IF 11.63)
86.
Gotsman I, Lotan C, Mosseri M.
Clinical manifestations and outcome of acute myocardial infarction in
very young patients.
Isr Med Assoc J 5: 633-6, 2003. (IF 0.54)
87.
Landesberg G, Shatz V, Akopnik I, Wolf YG, Mayer M, Berlatzky Y,
Weissman C, Mosseri M.
Association of cardiac troponin, CK-MB and postoperative myocardial
ischemia with long-term survival following major vascular surgery.
J Am Coll Cardiol (JACC) 42: 1547-54, 2003. (3/72, IF 9.20)
88.
Landesberg G, Mosseri M, Shatz V, Akopnik I, Bocher M, Mayer M,
Annr H, Berlatzky Y, Weissman C.
Cardiac troponin after major vascular surgery: the role of perioperative
ischemia, preoperative thallium scanning, and coronary
revascularization.
J Am Coll Cardiol (JACC) 965-59:)3(44, 2004. (3/72, IF 9.20)
89.
Dong S, Smorgick Y, Nahir, Lotan C, Mosseri M, Nassar H, Gotsman
MS, Hasin Y.
Predictors for successful angioplasty of chronic totally occluded
coronary arteries.
J Interv Cardiol 18(1):1-7, 2005. (IF 0.33)
90.
Mosseri M, Tamari I, Plich M, Hasin Y, Brizines M, Frimerman A,
Miller H, Jafari J, Guetta V, Solomon M, Lotan C.
Short and long term outcome of the Titanium-NO stent registry.
Cardiovasc Revasc Med 6(1); 2-6, 2005. (The journal is included in the
Index Medicus. IF is not yet available).
91.
Mosseri M, L. Satler, A. Pichard R. Waksman.
Impact of vessel calcification on outcome after coronary stenting.
Cardiovasc Revasc Med 6(4); 147-153, 2005. (The journal is included
in the Index Medicus. IF is not yet available).
92.
Mosseri M, Fisman EZ, Tenenbaum A.
Type 2 diabetes mellitus and cardiovascular diseases: Evaluation,
treatment and prevention strategies.
19
Name: Morris Mosseri
Degree: MD
CV: updated 1.4.2010
Harefuah 145(2); 1-6, 2006.
93.
Leibowitz D, Cohen M, Planer D, Mosseri M, Rott D, Lotan C, Weiss
AT.
Comparison of cardiovascular risk of noncardiac surgery following
coronary angioplasty with versus without stenting.
Am J Cardiol 97; 1188-91, 2006. (15/72, IF 3.05)
94.
Shochat M, Charach G, Meyler S, Kazatzker M, Mosseri M,
Rabinovich P, Shotan A, Meisel S.
Internal thoracic impedance monitoring: A new method for early
detection of cardiogenic pulmonary congestion at the pre-clinical stage.
Cardiovasc Revasc Med 7(1): 41-51, 2006. (The journal is included in
the Index Medicus. IF is not yet available).
95.
Shochat M, Charach G, Meyler S, Meisel S, Pelled B, Weintraub M,
Mengeritsky G, Mosseri M, Rabinovich P. (Mosseri and Rabinovich
senior authors).
Prediction of cardiogenic pulmonary edema onset by monitoring right
lung impedance.
Intensive Care Medicine 32(8): 1214-1221, 2006. (3/18, IF 3.72)
96.
Vitrella G, Sangiorgi G, Kornowski R, Mosseri M, Almagor Y,
Ischinger T, Pavlidis G, Rodermann J, Bartorelli A, Wijns W, Grube E,
Colombo A.
FX Minirail catheter usage for treatment of de-novo complex coronary
lesions: Results from the OFFAR registry.
J Interv Cardiol 19(3): 250-7, 2006. (IF 0.33)
97.
Mosseri M, Miller M, Tamari I , Plich M, Hasin Y, Brizines M,
Frimerman A, Jafary J, Guetta V, Solomon M, Lotan C.
The Titanium-NO Stent: Results of a Multicenter Registry.
EuroIntervention 2(2): 192-6, 2006. (IF not yet available).
98.
Alcalai R, Viola N, Mosseri M, Beeri R, Leibowitz D, Lotan C,
Gilon D.
The value of PCI in patients with symptomatic aortic stenosis and
coronary artery disease.
Am J Med 120(2): e7-13, 2007. (11/105, IF 4.38)
99.
Durst R, Lotan C, Nassar H, Gotsman M, Mor E, Varshitzki B,
Greganski P, Jabara R, Admon D, Meerkin D, Mosseri M.
Comparison of 4 & 6 French Catheters for Coronary Angiogarphy:
Real World Modeling.
Isr Med Assoc J 9: 290-293, 2007. (IF 0.54)
100.
Landesberg G, Berlatzky Y, Bocher M, Alcalai R, Anner H, Ganon T,
Luria MH, Akopnik I, Weissman C, Mosseri M.
A clinical scoring predicts long-term survival benefit of pre-operative
thallium scanning and coronary revascularization in patients
undergoing major vascular surgery.
Eur Heart J 28(5): 533-9, 2007. (4/72, IF 7.34).
20
Name: Morris Mosseri
Degree: MD
CV: updated 1.4.2010
101.
Guetta V, Mosseri M, Shechter M, Matetzky S, Assali A, Almagor Y,
Gruberg L, Benderly M, Lotan C, Kornowski R, for the UpFlow MI
Study Investigators.
Safety and efficacy of the FilterWire EZ in acute ST-Segment
elevation myocardial infarction.
Am J Cardiol 99(7): A3-5, 2007. (15/72, IF 3.05)
102.
Landesberg G, Mosseri M.
Preoperative coronary revascularization in High-Risk Patients
Undergoing Vascular Surgery.
Anesthesia & Analgesia 106(3): 579-567, 2008. (7/22, IF 2.16)
103.
Tsvetkov H, Mosseri M.
Myocardial blush grade: an interventional method for assessing
myocardial perfusion.
Isr Med Assoc J. 10(6):465-7, 2008. (IF 0.54)
104.
Hod H, Halon D, Hammerman H, Hasdai D, Zahger D, Lewis B, Mosseri
M, Atar S. The new universal definition of myocardial infarction.
Harefuah. 148(1):60-4, 86, 2009. (Hebrew)
105.
Perioperative myocardial infarction. Landesberg G, Beattie WS, Mosseri
M, Jaffe AS. Circulation. 2009;119:2936-2944. (1/72, IF 11.63)
106.
Landesberg G and Mosseri M. Prophylactic Pre-Operative Coronary
Revascularization; Is the Phoenix Awakening? (Editorial) JACC 54(11),
997-8, 2009. (3/72, IF 9.20)
Leibowitz D, Lotan C, Katz I, Nassar H, Boguslavsky L, Mosseri M,
Jabara R, Varshitzsky B, Danenberg H, Weiss AT. Effect of gradual
computerized angioplasty on outcomes of patients undergoing coronary
stenting. Am J Cardiol. 2009, 104(2):223-6. (11/105, IF 4.38)
107.
108.
Pereg D, Berlin T, Mosseri M. Mean platelet volume on admission
correlates with impaired response to thrombolysis in patients with STelevation myocardial infarction. Platelets 21(2): 117-121, 2010.
21
Name: Morris Mosseri
Degree: MD
CV: updated 1.4.2010
Case Reports in Peer Reviewed Journals
1.
Ben-Hur N, Ashur C, Mosseri M.
An unusual case of median cleft lip with orbital hypertelorism - a
missing link in the classification.
Cleft Palate Journal 15(4): 365-368, 1978. (45/49, IF 0.57)
2.
Stalnikowitc R, Mosseri M, Shalev O.
Phenytoin induced arthritis.
Neurology 32(11): 1317-1318, 1982. (6/148, IF 5.05)
3.
Mosseri M, Eliakim A, Mogle P.
Perforation of the esophagus electrocardiographically mimicking
myocardial infarction.
Isr J Med Sci 22: 451-454, 1986. (IF 0.54)
4.
Milgalter E, Mosseri M, Uretzki G, Romanoff H.
Intra-aortic balloon entrapment; a complication of balloon perforation.
Ann Thorac Surg 42: 694-698, 1986. (24/72, IF 2.22)
5.
Mosseri M, Rosenheck S, Galoon E, Milgalter E, Gotsman MS.
Thrombolysis of a stuck and thrombosed prosthetic tricuspid valve
with a single dose of streptokinase.
Isr J Med Sci 24:114-116, 1988. (IF 0.54)
6.
Mosseri M, Ben-Ishay D.
Beneficial effect of pindolol in a case of keratoconjuctivitis sicca
induced by propranolol and atenolol.
Isr J Med Sci 24: 259-260, 1988. (IF 0.54)
7.
Mosseri M, Hasin Y, Admon D, Gotsman MS.
Thrombolytic therapy of a stenosed coronary vein bypass graft with
continuous intragraft streptokinase drip.
Cardiology 77: 318-321, 1990. (26/72, IF 2.09)
8.
Zahger D, Mosseri M, Pizov G, Lotan C, Admon D, Gotsman MS.
Acute septal myocardial infarction diagnosed by endomyocardial
biopsy in heart transplant recipient.
J Heart Lung Transplant 11: 1125-6, 1992. (16/72, IF 2.99)
9.
Rozenman Y, Mosseri M, Mereuta A, Gotsman MS.
Monoclonal antibodies against the IIb/IIIa platelet receptor to treat
acute thrombolytic occlusion of a coronary stent.
J Invasive Cardiol 10: 42-44, 1997. (IF 0.25)
10.
Fuchs S, Mosseri M, Gotsman MS, Rozenman Y.
Isolated right ventricular infraction following right coronary artery
stent implantation in patients with recent inferior myocardial
infarction.
J Invasive Cardiol 9: 586-589, 1997. (IF 0.25)
22
Name: Morris Mosseri
Degree: MD
CV: updated 1.4.2010
11.
Gotsman I, Mosseri M.
Acute myocardial infarction in a young women with normal coronary
arteries and a combined thrombophilia.
Int J Cardiol 99(3): 483-4, 2005. (32/72, IF 1.76)
12.
Mosseri M, Banai S, Jabara R, Lotan C, Rott D.
The straight wire sign. Recognizing guidwire exit during percutaneous
coronary intervention for chronic total occlusion: implications for
avoiding coronary perforation.
Int J Cardiol 216: e106-e108, 2007. (32/72, IF 1.76)
23
Name: Morris Mosseri
Degree: MD
CV: updated 1.4.2010
Chapters in Books
1.
Gotsman MS, Weiss AT, Rosenman Y, Lotan C, Zahger D, Mosseri
M. Prehospital Thrombolysis in Acute Myocardial Infarction Salvages
Myocardium in: Thrombolytic Therapy. Gerald Timmis. Blackwell
Publishing. 1988
2.
Gotsman MS, Lotan C, Weiss AT, Applebaum D, Sapoznikov D,
Hasin Y, Mosseri M. Early and prehospital thrombolytic therapy
in acute myocardial infarction. In: Limitation of Infarct Size.
Dougherty FC. Springer-Verlag. Heidelberg, Germany. 1988.
3.
Gotsman MS, Welber S, Sapoznikov D, Mosseri M, Weiss AT.
Computer interactive methods of regional left ventricular dysfunction
in isolated disease of the left anterior descending coronary artery. In:
Simulation and Control of the Cardiac System. Sideman S & Beyar R.
Hemisphere Publishing Corporation, New-York. 1988.
4.
Gotsman MS, Weiss AT, Mosseri M, Sapoznikov D, Pollak A, Welber
S. Early and prehospital thrombolytic therapy of acute myocardial
infarction. In: Actualizacion Cardiovascular. Ramiro Rivera. Aran
S.A. 1989.
5.
Gotsman MS, Welber S, Nassar H, Mosseri M, Waksman R,
Sapoznikov D, Admon D, Weiss AT, Rozenman. The angiographic
pathology of coronary atheroma - interpreting the coronary
arteriogram. In: Analysis and Stimulation of the Cardiac System;
Inhomogeneity and Imaging. Eds. Beyar R, Sideman S. Cambridge
UK. 1989.
6.
Gotsman MS, Welber S, Nassar H, Mosseri M, Waksman R,
Sapoznikov D, Admon D, Weiss AT, Rozenman Y. The angiographic
pathology of coronary atheroma - interpreting the coronary
arteriogram. Sideman S & Beyar R. Hemisphere Publishing
Corporation, New-York. 1991.
7.
Rozenman Y, Lotan C, Gilon D, Mosseri M, Sapoznikov D, Welber S,
Gotsman MS. Arterial remodeling after percutaneous transluminal
balloon angioplasty. In: Interactive phenomena in the Cardiac System.
Eds. Sideman S & Beyar R. Plenum Press, New-York. 1993.
8.
Gotsman MS, Lotan C, Mosseri M, Hasin Y, Rosenheck S, Weiss AT,
Rozenman Y. Coronary angiography in the acute coronary syndromes.
In: Syndromes of Atherosclerosis. Ed. Fuster V. Futura Publishing,
Armonk NY. 1996
9.
Gotsman MS, Mosseri M, Rozenman Y, Lotan C, Nassar H.
Atherosclerosis Studies by Intracoronary Ultrasound. In: Analytical
and quantitative cardiology: From Genetics to Function. Sideman S &
Beyar R. Plenum Press, New-York. 1997.
24
Name: Morris Mosseri
Degree: MD
CV: updated 1.4.2010
10.
Mosseri M, Weshler Z. External Irradiation for the Prevention of
Restenosis - Past and Future. In: Vascular brachytherapy. Waksman
R. Nucletron BV, Veenendaal, The Netherlands. 1998.
11.
Gotsman MS, Weiss AT, Rozenman Y, Lotan C, Zahger D, Mosseri
M. Prehospital thrombolysis in acute myocardial infarction salvages
myocardium, In: Thrombolytic therapy. Timmis GC. New-York.
1999.
12.
Gotsman MS, Rozenman Y, Lotan C, Mosseri M. Myocardial
infraction as a work accident - assessment of disability. Medizinischrechtliche Asspecte von Arbeitsufallen. Band II: Rehabilitation.
HVBG, Abteilung Offentlichkeitsarbeit, DZS GmbH, Essen, 1999.
13.
Mosseri M, Symon Z, Waksman R. Radiimmunotherapy in the
prevention of restenosis. In: Vascular brachytherapy. Ed: Waksman
R. Nucletron BV, Veenendaal, The Netherlands. 2001.
14.
Mosseri M. Intra-coronary brachytherapy for the prevention of
restenosis (Hebrew). In: Interventional Cardiology. Aurora. Tel-Aviv,
2002.
15.
Sternberg M, Mosseri M. The Sirolimus eluting (Cypher) stent. In:
Interventional Cardiology (Hebrew). Aurora Medical Publications.
Tel-Aviv, 2006.
16.
Mosseri M. Diabetes Mellitus and Cardio-vascular Diseases. In:
Diabetes (Hebrew). The Israeli Diabetes Association Publications.
Tel-Aviv, 2007 (in Hebrew).
17.
Sternberg M, Mosseri M. The "Cypher"-Sirolimus eluting stent. In: A
Current Perspective on Cardiac Catheterization and Imaging. Aurora
Medical Publications. Tel-Aviv, 2007.
18.
Mosseri M. Use of the Endeavor drug eluting stent (Hebrew). In:
Update in Heart Catheterization and Imaging. Aurora Medical
Publications. Tel-Aviv, 2008.
25
Name: Morris Mosseri
Degree: MD
CV: updated 1.4.2010
Invited Papers in Scientific Meetings
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
Yarom R, Admon D, Mosseri M. Capillary pathology in
endomyocarbiopsies. The Gordon Conference. Massachusetts USA.
July 30th, 1990.
Mosseri M, Schaper J, Admon D, Hasin Y, Gotsman MS,
Sapoznikov D, Yarom R. Coronary capillaries in patients with
congestive cardiomyopathy or angina pectoris with patent main
coronary arteries: Ultrastructural morphometry of endomyocardial
biopsies. Scientific Conference on Experimental and Clinical
Coronary Pathophysiology Am Heart Assoc August 8-11, 1990.
Mosseri M. Peripheral Vascular Disease; Who should intervene?
2nd International Meeting on Interventional Cardiology. Jerusalem,
Israel, June 30 - July 3, 1997.
Gotsman MS, Weiss AT, Rozenmann T, Lotan C, Zahger D, Mosseri
M. La thrombolyse a domicile: Une methode efficace pour prevenir
l’infarctus du myocarde. Le Risque Cardio-Vasculaire; 1eres
rencontres franco-israeliennes organisees par l’Amif. Jerusalem,
Israel, 1998.
Mosseri M. Algorythm for cardiac testing of the symptomatic
diabetic patient. Prevention of Macrovascular Disease in Diabetes
Mellitus. The Israeli Diabetes Society meeting. Tiberias, Israel July
29-30, 1999.
Mosseri M. Appropriate follow up after screening exercise test in the
diabetic patient. Prevention of Macrovascular Disease in Diabetes
Mellitus. The Israeli Diabetes Society meeting. Tiberias, Israel July
29-30, 1999.
Mosseri M, Symon Z, Waksman R. The use of Targeted RadioImmunpo-Therapy (TRIT) for constructing a radioactive stent.
Radiation Meeting. Herzlia, Israel 2.2000.
Mosseri M. Coronary brachytherapy for coronary in-stent restenosis.
The Weshler Memorial Brachytherapy Meeting. Jerusalem, Israel.
June 6, 2000.
Mosseri M. Current evaluation guidelines for the post MI patient. 8th
International Congress of Cardiothoracic and Vascular Anesthesia.
Tel-Aviv, Novembr 10-13, 2002.
Mosseri M, Landesberg G. Perioperative myocardial infarction in
non-cardiac surgery. The 5th International Congress on Coronary
Artery disease - From Prevention to Intervention. Florence, Italy,
October 19-22, 2003. The Journal of Coronary Artery Disease 5(1):
87, 2003.
Landesberg G, Mosseri M. Pre-operative assessment of the cardiac
patient. The 2nd Conference on Medicine in the Third Age. TelAviv, April 21, 2004.
Mosseri M, M Brizines, M Flich, A Frimerman, V Guetta, Y Hasin, J
Jeffery, H Miller, I Tamari, C Lotan. The Titan stent (El Stent Israeli
Con Oxido Nitroso). The 10thSOLACI meeting, Buenos Aires,
August 4-6, 2004.
Mosseri M, M Brizines, M Flich, A Frimerman, V Guetta, Y Hasin, J
Jeffery, H Miller, I Tamari, C Lotan. Le Stent TITAN: resultants du
Registre National Israelien. Francophonic meeting Paris, France,
October 6-9, 2004.
26
Name: Morris Mosseri
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
Degree: MD
CV: updated 1.4.2010
Mosseri M. The Titan Titanium-NO Stent: Design, rationale and
clinical results. 16th Annual Scientific Symposium of Transcatheter
Cardiovascular Therapeutics (TCT). Washington DC, USA.
September 27-October 1, 2004.
Mosseri M, Rozenman Y. Debate: The role of screening tests for
coronary artery disease in asymptomatic diabetic patients (Invited
lecture). The 16th Israeli Congress of General Practice – Family
Medicine. Tel-Aviv, Israel, December 8, 2004.
Mosseri M. Diabetes and ischemic heart disease (invited lecture).
The annual meeting of Family physicians in North Israel. Kefar
Tavor, Israel, February 9, 2005.
Mosseri M. Advantages and clinical results with a titanium-nitride
oxide stent. 17th Annual Scientific Symposium of Transcatheter
Cardiovascular Therapeutics (TCT). Washington DC, USA. October
16-21, 2005.
Mosseri M. Titan study. 6th International Congress on Coronary
Artery Disease: From Prevention to Intervention. Istanbul, Turkey,
October 29-November 1, 2005.
Mosseri M. The titan (titanium nitride oxide) stent - results of the
israeli multi-center registry. 15th Asian Pacific Congress of
Cardiology and 57th Annual Conference of Cardiological Society of
India. Mumbay, Idia, December 1-4, 2005.
Mosseri M. Endeavor clinical program - current data and future
directions. 7th Intrernational Congress on Coronary Artery Disease;
From Prevention to Intervention. Venice, Italy, October 7-10, 2007.
Mosseri M, Landesberg G. From vulnerable plaque and patient to
vulnerable period - acute coronary events during and after noncardiac surgery. 7th Intrernational Congress on Coronary Artery
Disease; From Prevention to Intervention. Venice, Italy, October 710, 2007.
Mosseri M, Rosenbaum E. Non-Culprit Angioplasty During Primary
PCI: It's Time to Treat! STEMI Session VII: The Open Artery
Hypothesis and Other Controversies19th Annual Scientific
Symposium of Transcatheter Cardiovascular Therapeutics (TCT).
Washington DC, USA. October 16-21, 2007.
Mosseri M, Rozenman Y. Why is the Elderly Special? From
Metabolic Differences to Revascularization Outcomes. 19th Annual
Scientific Symposium of Transcatheter Cardiovascular Therapeutics
(TCT). Washington DC, USA. October 16-21, 2007.
Mosseri M. When to perform coronary intervention in the elderly
patient. Rehabilitation of the elderly patient Meeting. Herzlia, Israel.
January 9, 2008.
Mosseri M. Ischemic heart disease in the elderly – a tailored
approach. Paris Course in Revascularization (PCR). Barcelona. May
15 (13-16), 2008.
27
Name: Morris Mosseri
26.
27.
28.
29.
30.
31.
32.
Degree: MD
CV: updated 1.4.2010
Mosseri M. Usage of Hemcon pad for femoral hemostasis - a
comparative open label trial. 20th Annual Scientific Symposium of
Transcatheter Cardiovascular Therapeutics (TCT). Washington DC,
October 12-17, 2008.
Mosseri M. The Titanium Nitride Oxide Coated stent: Do Clinical
Trial Results Suggest Lower Restenosis? 20th Annual Scientific
Symposium of Transcatheter Cardiovascular Therapeutics (TCT).
Washington DC, October 12-17, 2008.
Mosseri M. Session: Percutaneous Coronary Interventions and the
Delicate Balance between Bleeding and Thrombosis. Invited paper:
The Challenges of Large Thrombotic Burden; Integrative
Pharmacological and Interventional Strategies. Paris Course in
Revascularization (PCR). Barcelona. May 19-22, 2009.
Mosseri M. Session: Novel Targets for Management of High Risk
Patients. Invited paper: PPAR agonists and the heart – what is the
evidence. The Diabetic Heart Meeting of the Israeli Heart Society.
Haifa June 25-27, 2009.
Mosseri M. Invited paper: Treatment with PPAR agonists for the
prevention of cardiovascular disease. The Israeli National Congress
on Diabetes Mellitus. Tel-Aviv November 18 2009.
Mosseri M. Invited paper: Should we screen diabetic patients for
ischemic heart disease? The Israeli National Congress on Diabetes
Mellitus. Tel-Aviv November 18 2009.
Mosseri M. Session: Clinical Aspects of Intervention. Invited
paper: Prevention of contrast nephropathy. Innovations in
Cardiovascular Interventions Meeting. Tel-Aviv, Israel.
28
Name: Morris Mosseri
Degree: MD
CV: updated 1.4.2010
Papers Presented in Scientific Meetings
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
Fine DG, Sapoznikov D, Mosseri M, Gotsman MS. Three dimensional
echocardiographic left ventricular reconstruction. Non-invasive
Cardiac Imaging. Tel-Aviv, Israel. April 1-3, 1986.
Hasin Y, Mosseri M, Lotan C, Meyers S, Admon D, Goldstein Y,
Weiss AT, Gotsman MS. PTCA - a 2 year cumulative experience. 6th
European Congress on Diseases of the Chest. June, 15-19, 1986.
Fine DG, Sapoznikov D, Mosseri M, Gotsman MS. Computerized
three dimensional echocardiographic reconstruction. 6th European
Congress on the diseases of the Chest. June, 15-19, 1986.
Mosseri M, Admon D, Hasin Y, Kriwitzki M, Rosenheck S, Gotsman
MS. Percutaneous angioplasty of totally occluded coronary vein
bypass grafts. 35th annual meeting of the American College of
Angiology. October 9-14, 1988.
Nizan M, Sapoznikov D, Mosseri M, Gotsman MS, Mahler Y.
Comparison of geometric and densitometric techniques for the
measurement of left ventricular volume changes. Computers in
Cardiology. September 19-22, 1989.
Mosseri M, Gotsman MS, Rosenheck S, Hasin Y, Welber S,
Sapoznikov D, Lotan C. Acute myocardial infarction occurs after
specific isolated lesions in the coronary arteries. 1st International
symposium on heart failure. May 21-25, 1989.
Admon D, Gotsman MS, Mosseri M, Borman J, Shimon D, Yarom R.
Long term follow up after cardiac transplantation on cyclosporine
treatment. 1st international symposium on heart failure. May 21-25,
1989.
Mosseri M, Meir G, Lotan C, Hasin Y, Applebaum A, Rosenheck S,
Shimon DV, Gotsman MS. Localized coronary pathology predicts
conduction disturbances after coronary artery bypass grafting. Isr J
Med Sci 25: 475, 1989.
Rozenman Y, Gilon D, Wexler S, Nassar H, Lotan C, Mosseri M,
Weiss AT, Hasin Y, Gotsman MS. Total coronary occlusion late after
successful coronary angioplasty: Incidence and clinical manifestations.
Israel Heart Society Meeting, April 19-20, 1993.
Lotan C, Mosseri M, Rozenman Y, Gilon D, Hasin Y, Gotsman MS.
Mechanical and thrombolytic therapy of totally occluded venous
bypass grafts. Israel Heart Society Meeting, April 19-20, 1993.
Rozenman Y, Gilon D, Welber S, Sapoznikov D, Lotan C, Mosseri M,
Geist M, Hasin Y, Gotsman MS. Plasma lipoproteins and restenosis
after successful coronary angioplasty. Israel Heart Society Meeting,
April 19-20, 1993.
Rozenman Y, Mosseri M, Lotan C, Gotsman MS. The use of vascular
stents during percutaneous coronary revascularization. Israel Heart
Society meeting, April 25-26, 1994.
Weiss AT, Gilon D, Shviro I, Sapoznikov D, Rosenheck S, Mosseri M,
Lotan C, Rozenman Y, Gotsman MS. Prehospital thrombolysis in
acute MI reduces disability and improves patients quality of life - a
long term follow-up study. Israel Heart Society meeting, April 25-26,
1994.
29
Name: Morris Mosseri
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
Degree: MD
CV: updated 1.4.2010
Rozenman Y, Gilon D, Lotan C, Mosseri M, Nassar H, Gurevitch J,
Wexler D, Hasin Y, Weiss AT, Gotsman MS. Progression of coronary
artery disease after successful balloon angioplasty: Relation to the
angioplasty artery and to restenosis. Israel Heart Society meeting,
April 25-26, 1994.
Rozenman Y, Gilon D, Zelinger I, Lotan C, Mosseri M, Geist M,
Weiss AT, Hasin Y, Gotsman MS. One stage coronary artery
angiography and angioplasty. Israel Heart Society meeting, April 2526, 1994.
Lotan C, Mosseri M, Rozenman Y, Gilon D, Kanel CI, Gotsman MS.
Clinical profile and prognosis of women following acute myocardial
infarction. Israel Heart Society meeting, April 25-26, 1994.
Lotan C, Jonas M, Rozenman Y, Mosseri M, Ben Horin J, Rudnik L,
Hasin Y, Gotsman MS. Anterior non-Q myocardial infarction:
Comparison of an early invasive or early conservative strategies in
patients with non-Q wave anterior myocardial infarction. Israel Heart
Society Meeting, April 24-25, 1995.
Rozenman Y, Gilon D, Zelinger J, Sapoznikov D, Lotan C, Mosseri M,
Weiss AT, Hasin Y, Gotsman MS. Balloon angioplasty in patients
with unstable angina pectoris: importance of time delay therapy. Israel
Heart Society Meeting, April 24-25, 1995.
Rozenman Y, Gilon D, Zelinger J, Sapoznikov D, Lotan C, Mosseri
M, Weiss AT, Hasin Y, Gotsman MS. Age and gender related
differences in success, major and minor complication rates and the
duration of hospitalization after percutaneous transluminal coronary
angioplasty. Israel Heart Society Meeting, April 24-25, 1995.
Gotsman MS, Weiss AT, Hasin Y, Zahger D, Rozenman Y, Lotan C,
Welber S, Sapoznikov D, Mosseri M. Very early thrombolytic therapy
in acute myocardial infraction - the cumulative 10 year Jerusalem
experience. Israel Heart Society Meeting, April 24-25, 1995.
Mosseri M, Zolti E, Hasin Y, Isak T, Nahir M, Lotan C, Rozenman Y,
Ershov T, Gotsman MS. The diameter of the epicardial coronary
arteries in patients with small coronary artery disease. Israel Heart
Society Meeting, April 24-25, 1995.
Rozenman Y, Mosseri M, Lotan C, Hasin Y, Gotsman MS.
Percutaneous transluminal coronary angioplasty in octogenarians.
Israel Heart Society Meeting, April 24-25, 1995.
Nahir M, Mosseri M, Ershov T, Lotan C, Rozenman Y, Isak T, Zolti E,
Gotsman MS. The diameter of “normal coronaries” in patients with
diabetes mellitus and smoking or hypercholesterolemia. Israel Heart
Society Meeting, April 24-25, 1995.
Mosseri M, Ershov T, Rozenman Y, Lotan C, Admon D, Hasin Y,
Gotsman MS. Total occlusion of the right coronary artery:
Localization and significance. Israel Heart Society Meeting, April 1415, 1997.
Nechmad A, Merin G, Schwalb H, Borman J, Milgalter E, Gotsman
MS, Mosseri M. Amplitude and pattern of estrogen-induced
vasodilation of human mammary arteries in-vitro. Israel Heart Society
Meeting, April 14-15, 1997.
Mosseri M, Symon Z, Waksman R. The TRIT stent – a radioactive
stent constructed by targeted radioimmuno therapy. The Annual ACC
meeting. 3.2000.
30
Name: Morris Mosseri
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
Degree: MD
CV: updated 1.4.2010
Weiss AT, Katz Yoni, Mosseri M. Computerized indeflator at the
catheterization laboratory. The Annual ACC meeting 3.2000.
Mosseri M. Targeted Radiotherapy. The 2nd International Meeting on
Intensive Cardiac Care. Jerusalem, Israel. June 18-21, 2000.
Alcalai R, Mosseri M, Gilon D, Pollak A, Gotsman MS, Admon D,
Nassar H, Jabara R, Applebaum EY, Lotan C. The non-culprit lesion
in acute STEMI – to treat or not to treat. The 50th Annual Meeting of
the Israel Heart Society. Tel-Aviv, April 30-May 1, 2003.
Varshitzky B, Gerganski P, Mosseri M, Nassar H, AdmonD, Gotsman
MS, Jabara R, Ltan C. PCI in unprotected LM coronary artery disease:
Evolving indications. The 50th Annual Meeting of the Israel Heart
Society. Tel-Aviv, April 30-May 1, 2003.
Mosseri M, Meerkin D, Admon D, Varshiyzky B, Lotan C.
Implantation of covered stents for coronary artery peroration during
angioplasty. The 50th Annual Meeting of the Israel Heart Society. TelAviv, April 30 - May 1, 2003.
Bimbat M, Sapoznikov D, Mosseri M, Assaf Y, Bdolah-Abram T,
Vilensky L, Lotan C. Signficant improvement in exercise test accuracy
using the model based on Bayesian analysis of the standard ST
depression and exercise-induced chest pain exercise variables with
pretest probability estimated by Prior's method using 8 clinical
parameters. The 50th Annual Meeting of the Israel Heart Society. TelAviv, April 30-May 1, 2003.
Lotan C, Mosseri M, Nassar H, Admon D, Varshitzky B, Weiss AT,
Gotsman MS, Jabara R, Meerkin D. A new bifurcation stent delivery
system: A novel approach to a complex problem. The 50th Annual
Meeting of the Israel Heart Society. Tel-Aviv, April 30-May 1, 2003.
Weiss AT, Leibovitz D, Cohen M, Boukhobza R, Mosseri M, Lotan C.
Cradiovascular risk of non-cardiac surgery soon after coronary
angioplasty is not increased by stent use. The 50th Annual Meeting of
the Israel Heart Society. Tel-Aviv, April 30-May 1, 2003.
Harel-Lutski R, Mosseri M, Gilon D, Assaf Y. Missed diagnosis of
acute coronary syndrome in patients presenting to the emergency room
with chest pain. The 50th Annual Meeting of the Israel Heart Society.
Tel-Aviv, April 30-May 1, 2003.
Harel-Lutski R, Mosseri M, Gilon D, Assaf Y. Missed diagnosis of
acute coronary syndrome in the emergency room. Second
Mediterranean Emergency Medicine Congress. Sitges, Spain.
September 13-17, 2003.
Varshitzky B, Drimmer Z, Gerganski P, Gotsman MS, Marincheva G,
Mosseri M, Nassar H, Rozenman Y, Weiss AT, Lotan C. Influence of
compromised side branch after coronary stenting on long-term clinical
outcome. The 5th International Meeting on Interventional Cardiology:
Frontiers in Interventional Cardiology. Tel-Aviv, Israel, December 79, 2003.
Varshitzky B, Gerganski P, Borivker , Kreisberg B, Mosseri M, Nassar
H, Gotsman MS, Meerkin D, Lotan C. Malposition of ostial stents: A
frequently overlooked problem. The 5th International Meeting on
Interventional Cardiology: Frontiers in Interventional Cardiology. TelAviv, Israel, December 7-9, 2003.
31
Name: Morris Mosseri
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
Degree: MD
CV: updated 1.4.2010
Varshitzky B, Admon D, Gerganski P, Gotsman MS, Mosseri M,
Nassar H, Weiss AT, Lotan C. Stent implantation in partially protected
LMCA: angiographic and clinical features. The 5th International
Meeting on Interventional Cardiology: Frontiers in Interventional
Cardiology. Tel-Aviv, Israel, December 7-9, 2003.
Weiss AT, Abu-Gazala MM, Mosseri M, Katz I, Nassar H, Leibowitz
D, Boukhobza R, Varshitzky B, Jabara R, Meerkin D, Lotan C.
Computerized gradual balloon inflation is superior to standard manual
angioplasty. The 5th International Meeting on Interventional
Cardiology: Frontiers in Interventional Cardiology. Tel-Aviv, Israel,
December 7-9, 2003.
Admon D, Gotsman I, Mosseri M, Gilon D, Varshitsky B, Lotan C.
Percutaneous coronary intervention (PCI) after heart transplantation:
Angiographic and long term results. The 51st Annual Meeting of the
Israel Heart Society. Tel-Aviv, April 28-29, 2004.
Alcalai R, Pollak A, Varshitsky B, Mosseri M, Nassar H, Meerkin D,
Lotan C. Treatment of the non-culprit lesions in acute STEMI – a two
year follow-up. The 51st Annual Meeting of the Israel Heart Society.
Tel-Aviv, April 28-29, 2004.
Durst R, Lotan C, Nassar H, Gotsman M, Varshitsky B, Gerhansky P,
Jabara R, Meerkin D, Mosseri M. A randomized trial comparing 4
French and 6 French catheters in coronary angiography. The 51st
Annual Meeting of the Israel Heart Society. Tel-Aviv, April 28-29,
2004.
Mosseri M, Brizines M, Plich M, Frimerman A, Guetta V, Hasin Y,
Jeffery J, Miller H, Tamari I, Lotan C. The Titan stent – data from a
national registry. The 51st Annual Meeting of the Israel Heart Society.
Tel-Aviv, April 28-29, 2004.
Varshitsky B, Borivker N, Gerganski P, Mosseri M, Weiss AT, Lotan
C. Technical features of aorto-ostial coronary stenting. The 51st
Annual Meeting of the Israel Heart Society. Tel-Aviv, April 28-29,
2004.
Varshitsky B, Marincheva G, Gergansky P, Mosseri M, Alcalai R,
Admon D, Lotan C. The relationship between CK elevation after
stenting of the proximal LAD and long-term mortality. The 51st
Annual Meeting of the Israel Heart Society. Tel-Aviv, April 28-29,
2004.
Abdelrahman N, Brill A, Touretsky N, Mosseri E, Mosseri M, Varon
D. Platelet response to aspirin and clopidogrel in patients with
unstable angina – monitoring by the CPA test. The 51st Annual
Meeting of the Israel Heart Society. Tel-Aviv, April 28-29, 2004.
Gruberg L, Pechersky S, Beyar R, Ben Tzvi M, Hasdai D, Kornowski
R, Mosseri M, Guetta V, Ilia R. The impact of renal insufficiency in
patients undergoing percutaneous coronary intervention: Results from
the Israel Shakespear Registry. The 51st Annual Meeting of the Israel
Heart Society. Tel-Aviv, April 28-29, 2004.
Herz I, Jabara R, Ayzenberg O, Bazan S, Finkelstein A, George J,
Miller H, Mosseri M, Meerkin D, Gendelman G, Kusniec F, Keren G,
Lotan C. Early experience with a new dedicated stent and delivery
system for the treatment of bifurcation lesions in coronary arteries.
The 51st Annual Meeting of the Israel Heart Society. Tel-Aviv, April
28-29, 2004.
32
Name: Morris Mosseri
50.
51.
52.
53.
54.
55.
56.
57.
58.
59.
60.
Degree: MD
CV: updated 1.4.2010
Alcalai R, Viola N, Mosseri M, Beeri R, Lotan C, Giolon D. Should
PCI procedures replace aortic valve surgery and CABG in patients with
severe aortic stenosis with angina? The 51st Annual Meeting of the
Israel Heart Society. Tel-Aviv, April 28-29, 2004.
Varshitsky B, Viola N, Gergansky P, Marincheva G, Mosseri M,
Gotsman MS, Merin G, Elami A, Lotan C. Comparison of clinical
outcomes of PCI vs. CABG in patients with unprotected LM disease
and a high operative risk. The 51st Annual Meeting of the Israel Heart
Society. Tel-Aviv, April 28-29, 2004.
Cohen MJ, Pollak A, Weiss AT, Golman S, Mosseri M, Lotan C,
Brezis M. Reperfusion for acute myocardial infarction at Hadassah
hospitals: Performance assessment. The 51st Annual Meeting of the
Israel Heart Society. Tel-Aviv, April 28-29, 2004.
Bimbat M, Sapoznikov D, Assaf J, Bdolah-Abram T, Vilensky L,
Lotan C, Mosseri M. Comparison exercise test with 8 clinical
parameters Pryor’s method for predictiong angiographic coronary
artery disease. The 51st Annual Meeting of the Israel Heart Society.
Tel-Aviv, April 28-29, 2004.
Sgan-Cohen HD, Sela MN, Angie M, Mosseri M. Dental disease, oral
bacteria and coronary heart disease severity. The joint meeting of the
Continental European Division (CED), Scandinavian Division (NOF)
and Israeli Division (ID) of IADR. Istanbul, August 25-8, 2004.
Ouzan E, Bonnet JL, Mosseri M. Le stent Titan: Resultat du registre
national Israelien. VIe Congres Francophone de Cardiologie
Iinterventionelle. R‫י‬union commune avec le Groupe Atherome et
cardiologie interventionnelle de la Soci‫י‬t‫ י‬fransaise de cardiologie.
Paris, France 13–15 Octobre 2004.
Varshitzky B, Marincheva G, Gerganski P, Mosseri M, Gotsman MS,
Merin G, Ealmi A, Lotan C. Comparison of clinical outcome of PCI
vs. CABG in patients with unprotected LM disease and high operative
risk. Acute Cardiac Care Meeting of the Euorpean Society of
cardiology. Rome, Italy, October 17-20, 2004.
Varshitzky B, Viola N, Gerganski P, Marincheva G, Mosseri M,
Admon D, Lotan C. Angiographic analysis, CK level and long-term
mortality after PCI. Acute Cardiac Care Meeting of the Euorpean
Society of cardiology. Rome, Italy, October 17-20, 2004.
Sgan-Cohen HD, Sela MN, Angie M, Mosseri M. Association
between dental caries activity and coronary heart disease severity.
IADR/AADR/CADR 83rd General Session, Baltimore, March 9-12,
2005.
Grenadier E, Kerner A, Mosseri M, Roguin A, Mahul N, Amikam S,
Gruberg L, Cohen S, Gingold L, Boulos M, Lotan C, Beyar R. Various
true small vessels stenting (<2.5mm) bare metal and drug elluted.
Comparative trials. Acute intermediate and long term clinical and
angiographic results. The 52nd Annual Meeting of the Israel Heart
Society. Tel-Aviv, April 13-14, 2005.
Muady G, Rubinger D, Mosseri M. Effect of repeated angiographies
on contrast nephropathy. The 52nd Annual Meeting of the Israel Heart
Society. Tel-Aviv, April 13-14, 2005.
33
Name: Morris Mosseri
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
71.
Degree: MD
CV: updated 1.4.2010
Mosseri M, Waksman R. Impact of vessel calcification on outcome
after coronary stenting. The 52nd Annual Meeting of the Israel Heart
Society. Tel-Aviv, April 13-14, 2005.
Manaevitch Z, Manaevitch S, Mosseri M, Sherman Y, Kokotov S,
Dekhter R, Berlatsky Y, Lewis A. Use of fast high voltage pulses for
crossing atheromatous plaques. The 52nd Annual Meeting of the Israel
Heart Society. Tel-Aviv, April 13-14, 2005.
Abdelrahman N, Brill A, Touretsky N, Mosseri E, Lotan C, Pugatch T,
Varon D, Mosseri M. Dynamic responsiveness to aspirin in patients
undergoing pci. The 52nd Annual Meeting of the Israel Heart Society.
Tel-Aviv, April 13-14, 2005.
Alcalai R, Viola N, Mosseri M, Beeri R, Lotan C, Gilon D. The value
of pci in patients with symptomatic aortic stenosis and coronary artery
disease. The 52nd Annual Meeting of the Israel Heart Society. TelAviv, April 13-14, 2005.
Shochat M, Charach G, Meyler S, Pelled B, Weintraub M,
Mengeritsky G, Mosseri M, Rabinovich P, Meisel S. A new method
for detecting pre-clinical cardiogenic pulmonary edema. The 52nd
Annual Meeting of the Israel Heart Society. Tel-Aviv, April 13-14,
2005.
Gerganski P, Varshitzky B, Marincheva G, Mosseri M, Banai S,
Drimmer Z, Lotan C. Percutaneous approach in patients after cabg and
significant disease of lita to lad graft. The 52nd Annual Meeting of the
Israel Heart Society. Tel-Aviv, April 13-14, 2005.
Rott D, Leibowitz D, Mosseri M, Lotan C, Weiss AT. Outcome of
coronary artery stenting in patient treated by clopidogrel without
aspirin. The 52nd Annual Meeting of the Israel Heart Society. TelAviv, April 13-14, 2005.
Guetta V, Mosseri M, Matetzki S, Assali A, Almagor Y, Gruberg L,
Benderly M, Lotan C, Kornowski Ran. The UPFLOW MI – use of
protective FilterWire to improve flow in acute myocardial infarction –
a multicenter randomized study to evaluate the clinical safety and
efficacy of the FilterWire EZ in acute STEMI intervention. The 53rd
Annual Meeting of the Israel Heart Society. Tel-Aviv, April 26-27,
2006.
Durst R, Neumark Y, Pollak A, Mosseri M, Beeri R, Danenberg, H,
Friedlander Y, Leitersdorf E, Meiner V, Lotan C. Macrophage
scavenger receptor 1 is associated with atherosclerosis susceptibility
ikn human. The 53rd Annual Meeting of the Israel Heart Society. TelAviv, April 26-27, 2006.
M Mosseri, B Varshitski, AT Weiss, H Daneberg, H Nassar, D
Edelman, A Vigoda, A Bibas, MS Gotsman, C Lotan. Late results of
intracoronary brachytherapy with gamma radiation; implications for
drug eluting stents. The 53rd Annual Meeting of the Israel Heart
Society. Tel-Aviv, April 26-27, 2006.
Gerganski P, Tzvetkov H, Varshitzky B, Pollak A, Mosseri M, Lotan
C. Current approach to management of very elderly patients admitted
due to acute coronaty syndrome. The 53rd Annual Meeting of the
Israel Heart Society. Tel-Aviv, April 26-27, 2006.
34
Name: Morris Mosseri
72.
73.
74.
75.
76.
77.
78.
79.
80.
81.
82.
83.
Degree: MD
CV: updated 1.4.2010
Sternberg M, Varshitski B, Nassar H, Danenberg H, Admon D, Lotan
C, Mosseri M. Does Implantation of Stents Made of Different Metals
Cause Corrosion and Restenosis? The 53rd Annual Meeting of the
Israel Heart Society. Tel-Aviv, April 26-27, 2006.
Varshitzky B, Gerganski P, Mosseri M, Danenberg H, Weiss AT,
Lotan C. Role of bidirectional imaging for guidance in percutaneous
revascukarization of chronic total occlusion. The 53rd Annual Meeting
of the Israel Heart Society. Tel-Aviv, April 26-27, 2006.
A Pekar, M Bimbat, E Sivaks, Lotan C, Keren A, M Mosseri. Clinical
Prediction of Angiographic Coronary Artery Disease. The 53rd Annual
Meeting of the Israel Heart Society. Tel-Aviv, April 26-27, 2006.
Varshitzki B, Boguslavsky L, Gerganski P, Mosseri M, Danenberg H,
Drimmer Z, Lotan C. Ostial LAD stenting: Evaluation of angiographic
and clonical results. The 53rd Annual Meeting of the Israel Heart
Society. Tel-Aviv, April 26-27, 2006.
Durand E, Hamm C, Macaya CM, Georges JL, Coste P, Husted SE,
Mosseri M, Lafont A. A randomized controlled trial of eftifibatide in
patients presenting non-SR segment elevation acute myocardial
infarction treated with an invasive strategy. XVth world Congress of
Cardiology. Barcelona, Spain September 2-6, 2006.
Varshitzky B, Bovriker N, Lotan C, Mosseri M. A novel stent delivery
and positioning system for aort-ostial lesions. Innovations in
Cardiovascular Interventions (ICI) Conference. Tel-Aviv, December
3-5, 2006.
Sternberg M, Danenberg H, Nassar H, Varshitzky B, Admon D, Lotan
C, Mosseri M. Late In-Stent Restenosis - A Different Disease? The
54th Annual Meeting of the Israel Heart Society. Tel-Aviv, April 1819, 2007.
Weiss AT, Leibowitz D, Mosseri M, Katz I, Varshitzsky B, Nassar H,
Danenberg C, Lotan C. The value of computerized angioplasty in
patients undergoing coronary stenting: a prospective, randomized trial.
The 54th Annual Meeting of the Israel Heart Society. Tel-Aviv, April
18-19, 2007.
Planer D, Mosseri M, Lotan C. Clinical Outcome of Titanium-NitrideOxide Coated Stents: A Meta-Analysis of All Published Data. The 54th
Annual Meeting of the Israel Heart Society. Tel-Aviv, April 18-19,
2007.
Varshitzky B, Gerganski P, Danenberg H, Weiss AT, Admon D,
Nassar H, Mosseri M, Lotan C. Percutaneous Revascularization of
Complex Chronic Total Occlusion: The Role of Bidirectional Imaging.
The 54th Annual Meeting of the Israel Heart Society. Tel-Aviv, April
18-19, 2007.
Nassar H, Lapidus L, Gomziakov L, Varshitzky B, Danenberg H,
Mosseri M, Lotan C. Cardiac Catheterization in Extremely Elderly
Patients - Is it Really Contraindicated? The 54th Annual Meeting of the
Israel Heart Society. Tel-Aviv, April 18-19, 2007.
Gerganski P, Ofman P, Varshitzky B, Mosseri M, Danenberg H,
Kreisberg B, Lotan C. Clinical outcome of failed primary PCI in
patients with STEMI. The 54th Annual Meeting of the Israel Heart
Society. Tel-Aviv, April 18-19, 2007.
35
Name: Morris Mosseri
84.
85.
86.
87.
88.
89.
90.
91.
92.
93.
94.
95.
Degree: MD
CV: updated 1.4.2010
Non-culprit Artery Revascularization during Primary PCI in Real Life.
Korotinsky S, Polak A, Pausner H, Lotan C, Kimron L, Mosseri M.
The 54th Annual Meeting of the Israel Heart Society. Tel-Aviv, April
18-19, 2007.
Kornowski R, Guetta V, Mosseri M, Swartz R, Behar S. Clinical
characteristics and mortality outcome of ACS patients treated with bare
metal vs. drug eluting stents: Insight from the National ACSIS 2004
and 2006 registries. The 555th Annual Meeting of the Israel Heart
Society. Tel-Aviv, April 9-10, 2008.
Weiss AT, Leibowitz D, Danenberg H, Mosseri M, Katz I, Varshitzky
B, Nassar H, Lotan C. Computerized gradual angioplasty improves
outcome of coronary stenting – final results of a randomized controlled
study. The 555th Annual Meeting of the Israel Heart Society. TelAviv, April 9-10, 2008.
Rozenbaum E, Erel J, Arbel J, Levi A, Chetboun I, Mosseri M.
A method for reducing amount of contrast in patients at risk for
contrast nephropathy. The 555th Annual Meeting of the Israel Heart
Society. Tel-Aviv, April 9-10, 2008.
Rozenbaum E, Neuman Y, Perl L, Arbel J, Ophir M, Toledano M,
Mosseri M. Nitroglycerin administration into the left main coronary
artery: Immediate hemodynamic effects and mechanism. The 555th
Annual Meeting of the Israel Heart Society. Tel-Aviv, April 9-10,
2008.
Rozenbaum E, Werner M, Rathaus V, Chetboun I, Levi A, Margalit M,
Mosseri M. A new method for femoral sheath withdrawal using
elastic bandage compression. The 555th Annual Meeting of the Israel
Heart Society. Tel-Aviv, April 9-10, 2008.
Rozenbaum E, Arbel J, Nachmanzon C, Korzets Z, Podjarny E,
Mosseri M. A new method for femoral sheath withdrawal using
elastic bandage compression. The 555th Annual Meeting of the Israel
Heart Society. Tel-Aviv, April 9-10, 2008.
Kornowski R, Guetta V, Mosseri M, Shwartz R, Behar S.
Mortality outcome of ACS patients treated with bare metal vs. drug
eluting stents. Insight from the National ACSIS 2004 and 2006
registries. The 555th Annual Meeting of the Israel Heart Society. TelAviv, April 9-10, 2008.
Beinart R, Hod H, Hammerman H, Oieru D, Fefer P, Mosseri M,
Guetta V, Boyko V, Behar S, Matetzky S. Predictors and prevalence
of early stent thrombosis in patients with acute coronary syndrome.
The 555th Annual Meeting of the Israel Heart Society. Tel-Aviv, April
9-10, 2008.
Perl L, Behar S, Shwartz R, Mosseri M. The effect of secondary
prevention on recurrent MI: Results from the 2004 and 2006 ACSIS
surveys. The 555th Annual Meeting of the Israel Heart Society. TelAviv, April 9-10, 2008.
Perl L, Behar S, Shwartz R, Mosseri M. Characteristics of recurrent
versus first AMI: Results from the 2004 and 2006 ACSIS surveys.
The 555th Annual Meeting of the Israel Heart Society. Tel-Aviv, April
9-10, 2008.
Vilchinsky N, Haze-Filderman L, Leibowitz M, Reges O, Erez N, Elal
R, Bental R, Manor D, Levit O, Khaskia A, Mosseri M, Daniel D.
36
Name: Morris Mosseri
96.
97.
98.
99.
100.
101.
102.
103.
104.
105.
106.
Degree: MD
CV: updated 1.4.2010
Patients personality and spouses' ways of giving support: Which
contributes more to the recovery after first ACS? The 555th Annual
Meeting of the Israel Heart Society. Tel-Aviv, April 9-10, 2008.
Gotlieb S, Roth A, Atar S, Kimron L, Fuchs S, Mosseri M, Behar S.
Characteristics, management and outcome of high risk NSTE-ACS
patients managed medically. The 565th Annual Meeting of the Israel
Heart Society. Tel-Aviv, April 22-23, 2009.
Neuman Y, Boyko V, Behar S, Mosseri M. Primary angioplasty in
patients following coronary artery bypass surgery; Trends in
application and outcome results from the Acute Coronary Syndromes
Israel Survey (ACSIS) 2000-2008. The 565th Annual Meeting of the
Israel Heart Society. Tel-Aviv, April 22-23, 2009.
Pereg D, Benderky M, Behar S, Mosseri M. Decreased renal function
associated with incident adverse cardiovascular outcomes in patients
with acute coronary syndromes. The 565th Annual Meeting of the Israel
Heart Society. Tel-Aviv, April 22-23, 2009.
Keren A, Potekhin M, Gotsman I, Zwas D, Mosseri M, Beeri R,
Leibowitz D, Levin G, Danenberg H, Pollak A, Admon D, Lotan C.
Clinical and hemodynamic outcome of inferobasal wall injury
complicating alcohol septal ablation in hypertrophic cardiomyopathy.
The 565th Annual Meeting of the Israel Heart Society. Tel-Aviv, April
22-23, 2009.
Pereg D, Mosseri M. Mean platelet volume on admission correlates
with impaired reperfusion in patients with acute myocardial infarction
treated with thrombolysis. The 565th Annual Meeting of the Israel
Heart Society. Tel-Aviv, April 22-23, 2009.
Arbel J, Rozenbaum E, Levi A, Erel J, Neuman Y, Caneti M, Reges O,
Erez N, Aharonof M, Mosseri M. Usage of Hemcon pad for femoral
hemostasis after percutaneous procedures – a comparative open label
trial. The 565th Annual Meeting of the Israel Heart Society. Tel-Aviv,
April 22-23, 2009.
Berlin T, Rozenbaum E, Arbel J, Reges O, Erel J, Chetboun I, Mosseri
M. Six months and one year clinical outcomes after implantation of
Prokinetic BMS in patients with acute coronary syndromes. The 565th
Annual Meeting of the Israel Heart Society. Tel-Aviv, April 22-23,
2009.
Mosseri M. Late Breaking Trials Session - New Trials and Registries.
Usage of Chitosan for femoral hemostasis after percutaneous
procedures – a comparative open labeled randomized study. Paris
Course in Revascularization (PCR). Barcelona. May 19-22, 2009.
Pereg D, Gow R, Mosseri M, Lishner M, Koren G. Hair cortisol and
the risk for acute myocardial infarction. The 575th Annual Meeting of
the Israel Heart Society. Tel-Aviv, April 14-15, 2010.
Segev A, Gotlieb S, Atar S, Roth A, Nahir M, Mosseri M, Danenberg
H, Kornowski R, Behar S. Trends of coronary procedures among
patients with Acute Coronary Syndrome in Israel (ACSIS 2002-1008).
The 575th Annual Meeting of the Israel Heart Society. Tel-Aviv, April
14-15, 2010.
Haze-Filderman L, Leibowitz M, Reges O, Khaskia A, Levit O, Elal R,
Mosseri M, Vilchinsky N. Spousal support and cardiac patients'
distress: The moderating role of attachment orientation. The 575th
37
Name: Morris Mosseri
107.
Degree: MD
CV: updated 1.4.2010
Annual Meeting of the Israel Heart Society. Tel-Aviv, April 14-15,
2010.
Yaacov M, Leibowitz M, Reges O, Khaskia A, Mosseri M, Vilchinsky
N. Type D personality, the Israeli sample; Initial validation and new
questions. The 575th Annual Meeting of the Israel Heart Society. TelAviv, April 14-15, 2010.
38
Name: Morris Mosseri
Degree: MD
CV: updated 1.4.2010
Abstracts and Proceedings
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
Grisaru D, Hasin Y, Goldfarb A, Mosseri M, Rachmilewitz E,
Gotsman MS, Lafair JS. Cardiopulmonary assessment in the
thalassemia major. Circulation 74: II-129, 1986.
Rosenheck S, Hasin Y, Mosseri M, Lotan C, Weiss AT, Gotsman MS.
Improvement in left ventricular function following PTCA performed
several months past transmural myocardial infarction treated by
intravenous streptokinase. Circulation 74: II-23, 1986.
Mosseri M, Porath A, Ovsyshcher I, Stone D. Electrocardiographic
manifestations of combined hypercalcemia and hypermagnesemia
caused by near drowning in the Dead Sea. Isr J Med Sci 25: 470, 1989.
Gal DVM, Chokshi SK, Mosseri M, DeJesus ST, Clarke R, Isner JM.
Low evel laser energy delivered percutaneously in vivo reverses spasm
induced by administration of intra-arterial histamine to atherosclerotic
microswine. J Am Coll Cardiol 15(2): 225A, 1990.
Mosseri M, Chokshi SK, Gal D, DeJesus S, Clarke R, Sierra R, Isner
JM. Vasomotor reactivity resulting from microsecond- length pulseduration pulsed laser irradiation in vitro. Lasers Surgery and Medicine
2:15, 1990.
Mosseri M, Chokshi SK, Isner JM, Fingert HJ. 5-FU induced
vasoconstriction in isolated rabbit aortic rings. Proceedings of the
American Association for Cancer Research 31: 443, 1990.
Isner JM, Rosenfield K, Mosseri M, Langevin E, Palefski P, Losordo
D, Razvi S. How reliable are images obtained by intravascular
ultrasound for making decisions during percutaneous interventions.
Experience with intravascular ultrasound employed in lieu of contrast
angiography to guide peripheral balloon angioplasty in 16 patients.
Circulation 82(4): III-493, 1990.
Pickering JG, Mosseri M, Chokshi SK, Gal D, Isner JM. Laser
induced vasoconstriction is not dependent on intact surface membrane
or calcium release. Circulation 82(4): III-494, 1990.
Mosseri M, Chokshi SK, Pickering JG, Gal D, Sierra R, Isner JM.
Effect of pulse duration on vasomotor response to pulsed dye laser
irradiation. Circulation 82(4): III-493, 1990.
Mosseri M, Rosenfield K, Losordo D, Dew R, Harding M, Isner JM.
Vasomotor reactivity of lower extremity peripheral vasculature in
humans evaluated by intravascular ultrasound. Circulation 82(4): III33, 1990.
Mosseri M, Chokshi SK, Pickering JG, Gal D, Isner JM. Cellular
mechanisms associated with vasoconstriction induced by continuous
wave laser irradiation. Circulation 82(4): III-339, 1990.
Pickering JG, Mosseri M, Hogan J, Isner JM. Unique vasomotor
response to pulsed Holmium:YAG laser irradiation in vitro. J Am Coll
Cardiol 17: 207A, 1991.
Mosseri M, Fingert H, Chokshi SK, Gal D, Isner JM. 5- Fluorouracil
induces vasoconstriction of vascular smooth muscle in vitro: Evidence
that vasospasm is the basis for cardiovascular and cerebrovascular
ischemic complications of 5-Fluorouracil. J Am Coll Cardiol 17:
138A, 1991.
39
Name: Morris Mosseri
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
Degree: MD
CV: updated 1.4.2010
Mosseri M, Weinstein R, Isner JM, Wenc K. Sickle erythrocytes
inhibit endothelium-dependent relaxing factor. J Am Coll Cardiol 17:
122A, 1991.
Mosseri M, Varticovski L, Fingert H, Chokshi SH, Isner JM. 5Fluorouracil induces protein kinase C-mediated vasoconstriction of
vascular smooth muscle in-vitro . J Am Coll Cardiol 19: 29A, 1992.
Weiss AT, Katz I, Lotan C, Rozenman Y, Mosseri M, Nassar H,
Mahler Y, Gotsman MS. Computerized, automatic pressure sensor and
inflator device - a new technique for safer, gradual dilatation of
coronary stenosis. J Invasive Cardiol 7: 13C; 1995.
Lotan C, Jonas M, Rozenman Y, Mosseri M, Benhorin J, Rudnik L,
Hasin Y, Gotsman MS. Comparison of an early invasive and
conservative treatment in patients with anterior non-Q wave
myocardial infarction. J Invasive Cardiology 7: 34C; 1995.
Lotan C, Hasin Y, Mosseri M, Rozenman Y, Gotsman Y. Transradial
approach for coronary angiography and angioplasty - experience with
the first 100 patients. J Invasive Cardiology 7: 30C; 1995.
Gotsman MS, Weiss AT, Hasin Y, Zahger D, Rozenman Y, Lotan C,
Welber S, Sapoznikov D, Mosseri M, Gilon D. Very early
thrombolytic therapy in acute myocardial infarction - the cumulative
10 year Jerusalem experience. Isr J Med Sci 32: S44, 1996.
Mosseri M, Izak T, Lotan C, Rozenman Y, Admon D, Gotsman MS.
Coronary angiographic characteristics of patients with permanent
artificial pacemaker. Isr J Med Sci 32: S42, 1996.
Lotan C, Rozenman Y, Mosseri M, Admon D, Zahger D, Hasin Y,
Nassar H, Kaniel CI, Gotsman MS. Predictors for mortality from acute
myocardial infarction: Who and why? Isr J Med Sci 32: S42, 1996.
Rozenman Y, Lotan C, Mosseri M, Nassar H, Hasin Y, Gotsman MS.
Experience with the new AVE Microstent in coronary artery
revascularization. Isr J Med Sci 32: S17, 1996.
Lotan C, Rozenman Y, Mosseri M, Nassar H, Admon D, Gurevitch J,
Hasin Y, Gotsman MS. Initial experience with the less shortening wall
stent for long degenerated lesions. Isr J Med Sci 32: S42, 1996.
Mosseri M, Rozenman Y, Lotan C, Nassar H, Admon D, Gotsman MS.
3-Dimensional reconstruction of AVE Microstents studied with
intravascular ultrasound. Isr J Med Sci 32: S42, 1996.
Weiss AT, Katz I, Mosseri M, Rozenman Y, Nassar H, Mahler Y,
Rosenheck S, Gotsman MS. Pressure volume curves during
computerized angioplasty - insight into mechanisms of angioplasty and
restenosis. Isr J Med Sci 32: S42, 1996.
WeissAT, Katz I, Lotan C, Rozenman Y, Mosseri M, Nassar H,
Mahler Y, Gotsman MS. Computerized, automatic pressure sensor and
indeflator device (CAPSID) - a new technique for safer gradual
dilatation of coronary stenosis. Isr J Med Sci 32: S43, 1996.
Rozenman Y, Lotan C, Mosseri M, Nassar H, Hasin Y, Gotsman MS.
New device left main angioplasty for patients with recurrent angina
pectoris early after coronary artery bypass surgery. Isr J Med Sci 32:
S17, 1996.
Lotan C, Hasin Y, Rozenman Y, Mosseri M, Admon D, Nassar H,
Gotsman MS. Clinical applicability of the transradial approach for
coronary angioplasty. Isr J Med Sci 32: S41, 1996.
40
Name: Morris Mosseri
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
Degree: MD
CV: updated 1.4.2010
Mosseri M, Rozenman Y, Lotan C, Nassar H, Admon D, Gotsman MS.
Intravascular coronary Doppler Flowire examinations: Initial
experience. Isr J Med Sci 32: S42, 1996.
Nechmad A, Merin G, Schwalb H, Shimon DV, Borman JB, Milgalter
E, Gotsman MS, Mosseri M. Estrogen induces nitric oxide-mediated
vasodilation of human mammary arteries in-vitro. Circulation 94: I279, 1996.
Weiss AT, Katz I, Lotan C, Rozenman Y, Mosseri M, Nassar H,
Gotsman MS. A randomized study of two computerized gradual
inflation PTCA protocols. J Invasive Cardiol 9: 7C, 1997.
Nassar H, Rozenman Y, Lotan C, Mosseri M, Hasin Y, Pollak A, Gilon
D, Weiss AT, Gotsman MS. Comparative results in percutaneous
mitral valvuloplasty: The double-balloon and Inoue techniques. J
Invasive Cardiol 9: 11C, 1997.
Rozenman Y, Mereuta A, Mosseri M, Lotan C, Nassar H, Hasin Y,
Gotsman MS. Initial experience with long coronary stents - the
changing practice of coronary angioplasty. J Invasive Cardiol 9: 23C,
1997.
Mosseri M, Rozenman Y, Lotan C, Nassar H, Weiss AT, Gotsman MS.
Lack of Glagovian remodeling in atherosclerotic orifice of the left
main and right coronary arteries. J Invasive Cardiol 9: 76C, 1997.
Rozenman Y, Sapoznikov D, Mosseri M, Gilon D, Lotan C, Nassar H,
Weiss AT, Hasin Y, Gotsman MS. Long term angiographic follow-up
of coronary balloon angioplasty in patients with diabetes mellitus: A
clue to the explanation of the results of the BARI study. J Invasive
Cardiol 9: 23C, 1997.
Weiss AT, Lotan C, Katz I, Rozenman Y, Mosseri M, Nassar H,
Gotsman MS. Pressure volume curves reflect mechanisms of coronary
angioplasty and predict restenosis. J Invasive Cardiol 9: 62C, 1997.
Weiss AT, Rozenman Y, Mosseri M, Katz I, Lotan C, Nassar H,
Gotsman MS. Assessment of optimal stent implantation using
computerized pressure-volume curves. J Invasive Cardiol 9: 75C,
1997.
Gare M, Haviv YG, Ben-Yehuda A, Rubinger D, Bdolah-Abram T,
Fuchs S, Gat O, Popovtzer MM, Gotsman MS, Mosseri M. Low dose
dopamine has no renal protective effect in high risk patients
undergoing coronary angiography. J Isr Heart Soc (Suppl) 19:18,1998.
Weiss AT, Rozenman Y, Mosseri M, Katz I, Lotan C, Nassar C,
Gotsman MS. The use of computerized pressure-volume curves for
optimal stent implantation. J Isr Heart Soc (Suppl) 19:14,1998.
Rozenman Y, Mereuta A, Schechter D, Mosseri M, Lotan C, Nassar H,
Weiss AT, Hasin Y, Chisin R, Gotsman MS. The long term outcome
of patients with very long stents for treatment of diffuse coronary
disease. J Isr Heart Soc (Suppl) 19:15,1998.
Weiss AT, Katz I, Lotan C, Rozenman Y, Mosseri M, Nassar H,
Gotsman MS. A randomized study of two computerized gradual
inflation PTCA protocols. J Isr Heart Soc (Suppl) 19:53,1998.
Lotan C, Gurevitch Y, Rozenman Y, Mosseri M, Nassar H, Admon D,
Hasin Y, Gotsman MS. Characterization of patients undergoing
repeated coronary interventions. J Isr Heart Soc (Suppl) 19:18, 1998.
41
Name: Morris Mosseri
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
Degree: MD
CV: updated 1.4.2010
Weiss AT, Rozenman Y, Katz I, Lotan C, Mosseri M, Nassar H,
Gotsman MS. A randomized study of two computerized gradual
inflation protocols (intermittent vs. continuous) during coronary
angioplasy. Int J Cardiovasc Interventions 2: 44, 1999.
Haviv B, Weshler Z, Schwalb H, Mosseri M. Ionizing beam
irradiation increases endothelium-dependent vasorelaxation of rat
thoracic aorta in-vitro. Int J Cardiovasc Interventions 2: 33, 1999.
Weiss AT, Rozenman Y, Mosseri M, Lotan C, Katz I, Nassar H,
Gotsman MS. Computerized automatic pressure sensor and inflator
device (CAPSID) reduces the need for stenting and revascularization.
Int J Cardiovasc Interventions 2: 13, 1999.
Mosseri M, Vodovotz Y, Symon Z, Chan R, Lu R, Waksman R.
Gamma emitting radioactive stent constructed by targeted
radioimmunotherapy. J Isr Heart Soc 3: 9, 2000.
Mosseri M, Lotan C, Edelman D, Nassar H, Hasin Y, Vigoda A, Bibas
A, Gotsman MS. Intracoronary gamma radiation for patients with instent restenosis - initial experience. J Isr Heart Soc 3: 43, 2000.
Lotan C, Mosseri M, Edelman D, Nassar H, Admon D, Hasin Y,
Gotsman MS. Importance of appropriate selection of patients for
intravascular brachytherapy for in-stent restenosis. J Isr Heart Soc 3:
32, 2000.
Lotan H, Nassar H, Mosseri M, Admon D, Gilon D, Pollack A, Hasin
Y, Gotsman MS. The cutting balloon: A unique technology with
maturing indications. J Isr Heart Soc 3: 54, 2000.
Haviv B, Schwalb H, Weshler Z, Mosseri M. The effect of ionizing
beam radiation on vasoreactivity in the rat thoracic aorta. J Isr Heart
Soc 3: 54, 2000.
Mosseri M, Landesberg G. Perioperative myocardial infarction in noncardiac surgery. The 5th International Congress on Coronary Artery
disease - From Prevention to Intervention. Florence, Italy, October 1922, 2003. Coronary Artery Disease 5(1): 87, 2003.
Dong S, Smorgick Y, Nahir , Lotan C, Mosseri M, Nassar H, Gotsman
MS, Hasin Y. Predictors of successful angioplasty for coronary artery
chronic total occlusion. J Isr Heart Soc 4: 1, 2001.
Lotan C,Bartorelli A, Galli A, Kiemeneij F, Van Den Branden,
Mosseri M, Legrand V, Hertz I, Reiber JHC, Rothman M. The smile
study: stenting with the multilink duet stent in long coronary lesions. J
Isr Heart Soc 4: 27, 2001.
Mosseri M, Lotan C, Edelman D, Nassar H, Nahir M, Vigoda A, Hasin
Y, Bibas A, Gotsman MS. Intracoronary gamma radiation for in-stent
restenosis – the real world. J Isr Heart Soc 4: 34, 2001.
Lotan C, Nassar H, Mosseri M, Gotsman MS, Admon D, Jebara R,
Hasin Y. The cutting balloon: a unique technology with maturing
indications. J Isr Heart Soc 4: 50, 2001.
Percutaneous coronary interventions in nonagenarians. Mosseri M, C.
Lotan, Y. Hasin, MS Gotsman, M. Nahir, H. Nassar, D. Gilon. J Isr
Heart Soc 4: 57, 2001.
P. Fefer, O. Biton, H. Schwalb, M. Mosseri, D. Tzivoni, D. Meerkin,
The effects of red wine on endothelial function in a rabbit arterial
model. J Isr Heart Soc 1: 41, 2002.
42
Name: Morris Mosseri
58.
59.
60.
61.
62.
63.
64.
65.
Degree: MD
CV: updated 1.4.2010
Bimbat M, Sapoznikov D, Mosseri M, Gilon D, Lotan C. Potential
improvement of the diagnostic accuracy of exercise testing: Tole of
multivariate approach combined with probability analysis. J Isr Heart
Soc 1: 75, 2002.
Varshitzky B, Borivker N, Mosseri M, Nassar H, Weiss T, Gotsman
MS, Admon D, Lotan C. Effect of aorto-ostial segment angulation on
stent-to-vessel apposition in patients with aorto-ostial coronary lesions.
J Isr Heart Soc 1: 25, 2002.
Mosseri M, Nir Hadari, Avi Porat, Mervyn S Gotsman, Chaim Lotan.
Advanced gamma brachytherapy protocol for the treatment of in-stent
restenosis. J Isr Heart Soc 1: 55, 2002.
Gotsman I, C. Lotan, M.S. Gotsman, Mosseri M. Clinical
manifestations and outcome of acute myocardial infarction in very
young patients. J Isr Heart Soc 1: 30, 2002.
Varshitzky B, Borivker N, Mosseri M, Nassar H, Weiss T, Gotsman
MS, Lotan C. Aorto-ostial stenting: Evaluation of angiographic
results. J Isr Heart Soc 1: 4, 2002.
Mosseri M. The TITAN (Titanium-NO) stent – results from a national
Israeli registry. XXV Congresso Nazionale Della Societa Italiana Di
Cardiologia Invasiva. Proceedings of the GISE meeting, pp. 154-155,
Napoli, Italy, October 6-10, 2004.
Mosseri M. Titan study. 6th International Congress on Coronary
Artery Disease: From Prevention to Intervention. Istanbul, Turkey,
October 29-November 1, 2005. Coronary Artery Disease 6(1): 74-5,
2005.
Mosseri M, Landesberg G. From vulnerable plaque and patient to
vulnerable period. Proceedings of the 7th International Congress on
Coronary Artery Disease. Venice, Italy, October 7-10, 2007. New
Horizons in Coronary Artety Disease. pp. 213-219, 2007.
43
Name: Morris Mosseri
Degree: MD
CV: updated 1.4.2010
Other Publications
1. Mosseri M, Hasin Y, Gotsman MS. Coronary revascularization by
percutaneous transluminal coronary angioplasty for recurrent ischemic
pulmonary edema (letter).
Lancet i: 976, 1986. (2/105, IF 23.40)
2. Gotsman MS, Hasin Y, Mosseri M. Percutaneous transluminal coronary
angioplasty - a 2 year experience.
Basi Raz Ter 16(10): 51-56, 1986.
3. Sapoznikov D, Fine DG, Mosseri M, Gotsman MS. Left ventricular shape,
wall thickness and function based on 3- dimensional reconstruction
echocardiography.
Computers in Cardiology 13: 495-498, 1986.
4. Mosseri M, Yarom R, Gotsman MS, Hasin Y. Angina pectoris and small
coronary vessel disease.
Cardiology Board Review 4(7): 127-138, 1987.
5. Fine DG, Lotan C, Welber S, Weiss AT, Sapoznikov D, Mosseri M,
Rosenheck S, Hasin Y, Gotsman MS. Total ischemic pain duration in acute
myocardial infarction and its relation to outcome after streptokinase
treatment.
Cardiovasc World Rep 1: 23-28, 1988.
6. Rosenheck S, Lotan C, Hasin Y, Mosseri M, Weiss AT, Gotsman MS.
Reversal of ischemic left ventricular dysfunction after percutaneous
transluminal coronary angioplasty.
Cardiovasc World Report 1: 98-102, 1988.
7. Shapira Y, Gertel M, Mosseri M, Shapira SC, Davidson JT.
Trichlorethylene the forgotten anesthetic: an old drug in a modern setting.
Today's Anesthetist 3: 71-74, 1988.
8. Mosseri M, Hasin Y, Gotsman MS. Acute beta blocker withdrawal and
exchange by verapamil before PTCA.
Artery 15(3): 118-121, 1988.
9. Fine DG, Sapoznikov D, Mosseri M, Gotsman MS. Three dimensional
echocardiographic reconstruction: qualitative and quantitative evaluation of
left ventricular function.
Computer Methods and Programs in Biomedicine 26: 33-34, 1988.
10. Grisaru D, Mosseri M, Hasin Y, Goldfarb A, Rachmilewitz E, Gotsman MS.
Mitral valve prolapse in beta-thalassemia major.
Cardiovasc World Rep 1: 260-262, 1989.
11. Gotsman MS, Weiss AT, Mosseri M, Sapoznikov D, Admon D, Pollak A,
Welber S. Early thrombolytic therapy in acute myocardial infarction and the
role of prehospital management.
Eur J Emerg (JEUR) 2: 170-183, 1989.
12. Mosseri M, Hasin Y, Kupulewitz Y, Lotan C, Yarom R, Oren R, Admon D,
Gotsman MS. Coronary thrombi formation in acute coronary syndromes histologic confirmation obtained in-vivo by PTCA.
Cardiovasc World Rep 1: 250-253, 1989.
13. Leviner E, Tzukert AA, Mosseri M, Fisher D, Yosipovitch O, Pisanty S,
Markitziu A. Preoperative hemodynamic changes in ischemic heart disease
patients undergoing dental treatment.
Spec Care Dentist 12: 84-8, 1992.
44
Name: Morris Mosseri
Degree: MD
CV: updated 1.4.2010
14. Mosseri M, Gotsman MS. Predictors of conduction disturbances after
coronary bypass grafting (invited commentary).
Ann Thorac Surg 57: 1284-8, 1994. (24/72, IF 2.22)
15. Mosseri M. Diabetes mellitus and the cardiovascular system.
Internal Med Update 8: 5-8, 1995 (Review article in Hebrew).
16. Mosseri M. Intravascular Doppler measurements.
Cardiology Update 9: 13-17, 1995 (Review article in Hebrew).
17. Gotsman MS, Mosseri M. The biochemistry of cholesterol.
Cardiology Update 11: 7-8, 1995 (Review article in Hebrew).
18. Rozenman Y, Mosseri M, Lotan C, Hasin Y, Gotsman MS. Percutaneous
transluminal coronary angioplasty in octogenarians.
Am J Geriatric Cardiol 4(6): 32-41, 1995.
19. Erhardt L, MacLean A, Ilgenfritz K, Gelprin K, Blumenthal M for the
Fosinopril Efficacy/Safety Trial (FEST) Study group. Fosinopril attenuates
clinical deterioration and improves exercise tolerance in patients with heart
failure.
Eur Heart J 16: 1892-1899, 1995. (4/72, IF 7.34)
20. Gotsman MS, Gilon D, Lotan C, Mosseri M, Nassar H, Rozenman Y,
Sapoznikov D, Weiss AT, Zahger D. Very early thrombolysis in acute
myocardial infarction. The Jerusalem experience.
Pol Heart J 44: 6-16, 1996.
21. Mosseri M. Physiology of platelets, clotting anf fibrinolysis.
Internal Medicine Update 17: 23-5, 1997 (Review article in Hebrew).
22. Mosseri M. The coronary vascular bed in cardiomyopathies.
J Isr Heart Soc 18: 4-8, 1998 (Review article).
23. Mosseri M. Peripheral vascular disease; Who should intervene?
J Isr Heart Soc 19: 6-9, 1998 (Review article).
24. Mosseri M, Gare M, Rubinger D. Renal effect of low-dose dopamine in
high-risk patients undergoing coronary angiography (Invited commentary).
J Am Coll Cardiol (JACC) 36: 306-7, 2000. (3/72, IF 9.20)
25. Pollak A, Gotsman M, Mosseri M. Degeneration of a venous coronary
artery bypass conduit.
J Isr Heart Soc 10(1): 3-6, 2000.
26. Mosseri M, Ershov T, Gilon D, Pollak A, Admon D, Gotsman MS. Total
occulsion of the right coronary artery: Localization and significance.
J Isr Heart Soc 10(1): 12-19, 2000.
27. Serruys pw, de Bruyne b, Carlier S, Sousa JE, Piek J, Muramatsu T, Vrints
C, Probst P, Seabra-Gomes R, Simpson I, Voudris V, Gurné O, Pijls N,
Belardi J, van Es GA, Boersma E, Morel MA, van Hout B, on behalf of the
Doppler Endpoints Balloon Angioplasty Trial Europe (DEBATE) II Study
Group. Randomized Comparison of Primary Stenting and Provisional
Balloon Angioplasty Guided by Flow Velocity Measurement.
Circulation 102: 2930-37, 2000.
28. DiMario C, Moses JW, Anderson TJ,Bonan R, Muramatsu T, Jain AC, De
Lezo JS, Cho SY, Kern M, Meredith IT, Cohen D, Moussa I, Colombo A, on
behalf of the DESTINI Study Group. Randomized comparison of elective
stent implantation and coronary balloon angioplasty guided by online
quantitative angiograpgy and intracoronary Doppler.
Circulation 102: 2938-44, 2000.
29. Mosseri M, Weshler Z. Stereotactic radiotreatment and prevention of
restenosis.
United States Patent no. 6,093,141 July 25, 2000.
45
Name: Morris Mosseri
Degree: MD
CV: updated 1.4.2010
30. Mosseri M, Weshler Z. Stereotactic radiotreatment and prevention of
restenosis.
United States Patent no. 6,190,302. February 20, 2001.
31. Bimbat M, Sapoznikov D, Mosseri M, Assaf J, Bdolach-Abraham T,
Vilensky L, Lotan C. Improvement in exercise test accuracy using a
bayesian model.
J Isr Heart Society 13(1): 24-32, 2003.
32. Landesberg G, Mosseri M, Fleisher LA. Coronary revascularization before
vascular surgery (author reply).
NEJM 352(14): 1492-3, 2005. (1/105, IF 44.01).
33. Kaluski E, Uriel N, Hendler A, Kornowski R, Krakover R, Mosseri M.
Interventional cardiology in Israel at 2005 - state of practice.
Acute Card Care 9(2):104-10, 2007.
46
Name: Morris Mosseri
Degree: MD
CV: updated 1.4.2010
Participation in Recent Clinical Studies
(as Principal Investigator in Meir Medical Center)
1. MERILIN – TIMI 36: Metabolic efficiency with Ranolazine
for less ischemia in non ST elevation acute coronary syndromes. CVT Protocol # 3036.
2004-2007
2. TRITON TIMI 38- A comparison of CS-747 and Clopidogrel in acute
coronary syndrome subjects who are to undergo percutaneous coronary
intervention. Protocol H7T-MC-TAAL. 2005-2007
3. HERA - A randomized three – arm multi – centre comparison of 1year and 2 years
of herceptin versus no herceptin in women with HER2- positive primary breast who
have completed adjuvant chemotherapy. 2003- Ongoing
4. ORIGIN – (Outcome Reduction With Initial Glargine Intervention) 2004Ongoing
5. ACTIVE – Atrial Fibrillation Clopidogrel Trial with Irbesartan for
prevention of Vascular Events. A parallel randomized controlled
evaluation of clopidogrel plus aspirin, with factorial evaluation of
irbesartan, for the prevention of vascular events, in patients with atrial
fibrillation. 2005- Ongoing
6. ATHENA - Aplacebo-controlled, double-blind, parallel arm trial to
assess the efficacy of dronedarone 400mg bid for the prevention of
cardiovascular hospitalization or death from any cause in patients with atrial
fibrillation/ atrial flutter (AF/AFL) 2005-Ongoing
7. HORIZONS – Harmonizing Outcomes with RevascularIZatiON and Stents – A dual
arm factorial randomized trial in patients with ST elevation AMI to compare the results
of using either anticoagulation with unfractionated heparin plus routin IIb/IIIa inhibition
with bivalirudin and bail-out IIb/IIIa inhibition, and primary angioplasty with stent
implantation with either a slow rate-release paclitaxel-elutin stent (TAXUS) or an
otherwise identical uncoated bare metal stent (Express).
8. STORIES FROM THE HEART- The relation between denial and psychological
and physiological outcomes as expressed in the narratives of person with
cardiovascular disease.
9. APPRAISE-1 A Phase II, placebo controlled, randomized, double blind,
parallel arm, dose ranging study to evaluate safety and efficacy of
Apixaban in patients with a recent acute coronary syndrome. 2007-2008
47
Name: Morris Mosseri
Degree: MD
CV: updated 1.4.2010
10. CURRENT/OASIS 7: Randomized, multinational, double blind
study,comparing a high loading dose regimen of clopidogrel versus
standard dose in patients with unstable angina pectoris or non-ST
segment elevation myocardial infarction managed with an early invasive
strategy. 2007- Ongoing
11. BXT 203 - A randomized, double blind, placebo controlled, parallel
group study to determine the effect of BXT-51072 on CKMB in
high risk type 2 diabetic patients undergoing elective percutaneous
coronary intervention. 2007- Ongoing
12. NITRO- Timing and sequence of the effects of intra – coronary
nitroglycerin. 2007
13. IMPROVE-IT – A multicenter, double – blind, randomized study to establish the
clinical benefit and safety of vytorin (ezentimibe/simvastatin tablet) Vs. simvastatin
Monotherpy in high – risk subjects presenting with acute coronary syndrome (improved
reduction of outcomes: vytorin efficacy international trial. 2007- Ongoing
14. HEMCON- Usage of HemCon for femoral hemostasis after
percutaneous procedures. A comparative open label study. 2008- Ongoing
15. PROTECT- Patient related outcomes with endeavor versus cypher stenting trial.
2008- Ongoing
16. PRO-KINETIC – Retrospective survey on prokinetic stent
implantation during acute coronary syndrome. 2008-Ongoing
17. ARISTOTEL – Outcome reduction with Apixaban in preventing
stroke and systemic Embolism in subjects with nonvalvular atrial
fibrillation intervention. 2008- Ongoing
18. ACSIS - Acute coronary syndrome Israeli survey. 2008- Ongoing
19. TIMI-50- A Multicenter, Randomized, Double Blind, Placebo-Controlled Study To
Evaluate The Safety And Efficacy Of SCH 530348 In Addition To Standard Of Care In
Subjects With A History Of Atherosclerotic Disease: Thrombin Receptor Antagonist In
Secondary Prevention Of Atherothrombotic Ischemic Events. 2008-Ongoing
20. NOBORI 2 – A prospective, multi-center, observational study of the Nobori™ drug
eluting stent system. 2008- Ongoing
48
Name: Morris Mosseri
Degree: MD
CV: updated 1.4.2010
21. TRACER- A Multicenter, Randomized, Double Blind, Placebo-Controlled Study To
Evaluate The Safety And Efficacy Of SCH 530348 In Addition To Standard Of Care In
Subjects With Acute Coronary Syndrome: Thrombin Receptor Antagonist For Clinical
Event Reduction In Acute Coronary Syndrome. 2008- Ongoing
22. ROCHE- A phase III, double-blind, randomized placebo-controlled study, to
evaluate the effects of RO4607381 on cardiovascular (CV) risk in stable CHD patients,
with a documented recent Acute Coronary Syndrome (ACS) – protocol no. NC20971.
2008- Ongoing
23. H7T-MC-TABY- Phase 3, multicenter, randomized, parallel-group, double-blind,
double-dummy, active-controlled study. Acomparison of prasugrel and clopidogrel in
subjects with Unstable Angina/Non-ST – Elevation myocardial infarction
(UA/NSTEMI) acute coronary syndrome (ACS) who are medically managed.
2008- Ongoing
24. BLAST- Liposomal alendronate infusion in subjects undergoing bare metal
coronary stent implantation. 2009- Ongoing
25. KAI-9803-004 Study- Inhibition of δ-PROTEin kinase C for the reducTION of
infarct size in Acute myocardial infarction (PROTECTION AMI). 2009- Ongoing
26. Amgen RED HF - A Double-blind, Randomized, Placebo-controlled, Multicenter
Study to Assess the Efficacy and Safety of Darbepoetin alfa Treatment on Mortality and
Morbidity in Heart Failure (HF) Subjects with Symptomatic Left Ventricular Systolic
Dysfunction and Anemia. 2009- Ongoing
49